<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Parkinson&#039;s disease,Articles with unsourced statements since April 2009,Articles with trivia sections from August 2008,People with Parkinson&#039;s disease,Special:Search/Parkinson&#039;s disease,AIDS dementia complex,Abulia,Acetylcholinesterase inhibitor,Acute alcohol intoxication,Acute disseminated encephalomyelitis,Acute stress reaction" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Parkinson's disease - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Parkinson\'s_disease";
		var wgTitle = "Parkinson\'s disease";
		var wgAction = "view";
		var wgArticleId = "22228064";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 283182698;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = ["autoconfirmed"];
		var wgRestrictionMove = ["autoconfirmed"];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Parkinson_s_disease skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Parkinson's disease</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table class="infobox" width="200" cellspacing="0" style="font-size: 95%; text-align:left">
<tr>
<td style="text-align: center; background: lightgrey; font-size: 95%;" colspan="2"><b>Parkinson's disease</b><br />
<i>Classification and external resources</i></td>
</tr>
<tr>
<th colspan="2" style="text-align: center; font-size: smaller;">
<div class="center">
<div class="floatnone"><a href="/wiki/File:Sir_William_Richard_Gowers_Parkinson_Disease_sketch_1886.jpg" class="image" title="Sir William Richard Gowers Parkinson Disease sketch 1886.jpg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Sir_William_Richard_Gowers_Parkinson_Disease_sketch_1886.jpg/190px-Sir_William_Richard_Gowers_Parkinson_Disease_sketch_1886.jpg" width="190" height="229" border="0" /></a></div>
</div>
</th>
</tr>
<tr style="line-height: 1;">
<td colspan="2" style="text-align:center;"><small>Illustration of the Parkinson disease by Sir William Richard Gowers from <i>A Manual of Diseases of the Nervous System</i> in 1886</small></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-10_codes" title="List of ICD-10 codes" class="mw-redirect">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_G" title="ICD-10 Chapter G" class="mw-redirect">G</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gg20.htm+g20" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gg20.htm+g20" rel="nofollow">20.</a>, <a href="/wiki/ICD-10_Chapter_F" title="ICD-10 Chapter F" class="mw-redirect">F</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gf00.htm+f023" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gf00.htm+f023" rel="nofollow">02.3</a></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=332" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=332" rel="nofollow">332</a></td>
</tr>
<tr>
<th><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb9651.htm" class="external text" title="http://www.diseasesdatabase.com/ddb9651.htm" rel="nofollow">9651</a></td>
</tr>
<tr>
<th><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000755.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000755.htm" rel="nofollow">000755</a></td>
</tr>
<tr>
<th><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/neuro/topic304.htm" class="external text" title="http://www.emedicine.com/neuro/topic304.htm" rel="nofollow">neuro/304</a>&#160; <a href="http://www.emedicine.com/neuro/topic635.htm#" class="external text" title="http://www.emedicine.com/neuro/topic635.htm#" rel="nofollow">neuro/635</a> in young<br />
<a href="http://www.emedicine.com/pmr/topic99.htm#" class="external text" title="http://www.emedicine.com/pmr/topic99.htm#" rel="nofollow">pmr/99</a> rehab</td>
</tr>
<tr>
<th><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b></th>
<td><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D010300" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D010300" rel="nofollow">D010300</a></td>
</tr>
</table>
<p><b>Parkinson's disease</b> (also known as <b>Parkinson disease</b> or <b>PD</b>) is a <a href="/wiki/Degenerative_disease" title="Degenerative disease">degenerative disease</a> of the brain (<a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a>) that often impairs <a href="/wiki/Motor_skill" title="Motor skill">motor skills</a>, speech, and other functions.<sup id="cite_ref-Jankovic2008_0-0" class="reference"><a href="#cite_note-Jankovic2008-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>Parkinson's disease belongs to a group of conditions called <a href="/wiki/Movement_disorder" title="Movement disorder">movement disorders</a>. It is characterized by muscle rigidity, <a href="/wiki/Tremor" title="Tremor">tremor</a>, a slowing of physical movement (<a href="/wiki/Bradykinesia" title="Bradykinesia">bradykinesia</a>) and, in extreme cases, a loss of physical movement (<a href="/wiki/Akinesia" title="Akinesia">akinesia</a>). The primary symptoms are the results of decreased stimulation of the <a href="/wiki/Motor_cortex" title="Motor cortex">motor cortex</a> by the <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a>, normally caused by the insufficient formation and action of <a href="/wiki/Dopamine" title="Dopamine">dopamine</a>, which is produced in the <a href="/wiki/Dopaminergic_neuron" title="Dopaminergic neuron" class="mw-redirect">dopaminergic neurons</a> of the brain. Secondary symptoms may include high level cognitive dysfunction and subtle language problems. PD is both <a href="/wiki/Chronic_(medicine)" title="Chronic (medicine)">chronic</a> and progressive.</p>
<p>PD is the most common cause of chronic progressive <a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a>, a term which refers to the syndrome of tremor, rigidity, <a href="/wiki/Bradykinesia" title="Bradykinesia">bradykinesia</a> and postural instability. PD is also called "primary parkinsonism" or "<a href="/wiki/Idiopathic" title="Idiopathic">idiopathic</a> PD" (classically meaning having no known cause although many genetic mutations associated with PD have since been discovered). While many forms of parkinsonism are "idiopathic", "secondary" cases may result from toxicity most notably of drugs, head trauma, or other medical disorders. The disease is named after English physician <a href="/wiki/James_Parkinson" title="James Parkinson">James Parkinson</a>, who made a detailed description of the disease in his essay: "An Essay on the Shaking Palsy" (1817).</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a></li>
<li class="toclevel-1"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2"><a href="#Motor_symptoms"><span class="tocnumber">2.1</span> <span class="toctext">Motor symptoms</span></a></li>
<li class="toclevel-2"><a href="#Neuropsychiatric"><span class="tocnumber">2.2</span> <span class="toctext">Neuropsychiatric</span></a></li>
<li class="toclevel-2"><a href="#Sleep"><span class="tocnumber">2.3</span> <span class="toctext">Sleep</span></a></li>
<li class="toclevel-2"><a href="#Perception"><span class="tocnumber">2.4</span> <span class="toctext">Perception</span></a></li>
<li class="toclevel-2"><a href="#Autonomic"><span class="tocnumber">2.5</span> <span class="toctext">Autonomic</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Causes"><span class="tocnumber">3</span> <span class="toctext">Causes</span></a>
<ul>
<li class="toclevel-2"><a href="#Genetic"><span class="tocnumber">3.1</span> <span class="toctext">Genetic</span></a></li>
<li class="toclevel-2"><a href="#Toxins"><span class="tocnumber">3.2</span> <span class="toctext">Toxins</span></a></li>
<li class="toclevel-2"><a href="#Head_trauma"><span class="tocnumber">3.3</span> <span class="toctext">Head trauma</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Pathophysiology"><span class="tocnumber">4</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">5</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">6</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Levodopa"><span class="tocnumber">6.1</span> <span class="toctext">Levodopa</span></a></li>
<li class="toclevel-2"><a href="#COMT_inhibitors"><span class="tocnumber">6.2</span> <span class="toctext">COMT inhibitors</span></a></li>
<li class="toclevel-2"><a href="#Dopamine_agonists"><span class="tocnumber">6.3</span> <span class="toctext">Dopamine agonists</span></a></li>
<li class="toclevel-2"><a href="#MAO-B_inhibitors"><span class="tocnumber">6.4</span> <span class="toctext">MAO-B inhibitors</span></a></li>
<li class="toclevel-2"><a href="#Surgery_and_deep_brain_stimulation"><span class="tocnumber">6.5</span> <span class="toctext">Surgery and deep brain stimulation</span></a></li>
<li class="toclevel-2"><a href="#Neurorehabilitation"><span class="tocnumber">6.6</span> <span class="toctext">Neurorehabilitation</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prognosis"><span class="tocnumber">7</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1"><a href="#Epidemiology"><span class="tocnumber">8</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">9</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Research_directions"><span class="tocnumber">10</span> <span class="toctext">Research directions</span></a>
<ul>
<li class="toclevel-2"><a href="#Gene_therapy"><span class="tocnumber">10.1</span> <span class="toctext">Gene therapy</span></a></li>
<li class="toclevel-2"><a href="#Neuroprotective_agents"><span class="tocnumber">10.2</span> <span class="toctext">Neuroprotective agents</span></a></li>
<li class="toclevel-2"><a href="#Neural_transplantation"><span class="tocnumber">10.3</span> <span class="toctext">Neural transplantation</span></a></li>
<li class="toclevel-2"><a href="#Complementary_therapies"><span class="tocnumber">10.4</span> <span class="toctext">Complementary therapies</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Famous_sufferers"><span class="tocnumber">11</span> <span class="toctext">Famous sufferers</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">12</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">13</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">14</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Classification" id="Classification"></a></p>
<h2><span class="mw-headline">Classification</span></h2>
<p>"Parkinson's disease" is the synonym of "primary parkinsonism", i.e. isolated parkinsonism due to a neurodegenerative process without any secondary systemic cause. In some cases, it would be inaccurate to say that the cause is "unknown", because a small proportion is caused by genetic mutations. It is possible for a patient to be initially diagnosed with Parkinson's disease but then to develop additional features, requiring revision of the diagnosis.<sup id="cite_ref-nice35_1-0" class="reference"><a href="#cite_note-nice35-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<p>There are other disorders that are called <i><a href="/wiki/Parkinson_plus_syndrome" title="Parkinson plus syndrome">Parkinson-plus diseases</a></i>. These include: <a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">multiple system atrophy</a> (MSA), <a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">progressive supranuclear palsy</a> (PSP) and <a href="/wiki/Corticobasal_degeneration" title="Corticobasal degeneration">corticobasal degeneration</a> (CBD). Some include <a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">dementia with Lewy bodies</a> (DLB)—while idiopathic Parkinson's disease patients also have <a href="/wiki/Lewy_body" title="Lewy body">Lewy bodies</a>— abnormal aggregates of <a href="/wiki/Protein" title="Protein">protein</a> that develop inside <a href="/wiki/Nerve_cells" title="Nerve cells" class="mw-redirect">nerve cells</a> — in their brain tissue, the distribution is denser and more widespread in DLB. Even so, the relationship between Parkinson disease, Parkinson disease with dementia (PDD), and dementia with Lewy bodies (DLB) might be most accurately conceptualized as a spectrum, with a discrete area of overlap between each of the three disorders. The natural history and role of Lewy bodies is little understood.</p>
<p>These Parkinson-plus diseases may progress more quickly than typical idiopathic Parkinson disease. If cognitive dysfunction occurs before or very early in the course of the movement disorder then DLBD may be suspected. Early postural instability with minimal tremor especially in the context of ophthalmoparesis should suggest PSP. Early autonomic dysfunction including erectile dysfunction and syncope may suggest MSA. The presence of extreme asymmetry with patchy cortical cognitive defects such as dysphasia and apraxias especially with "alien limb" phenomena should suggest CBD.</p>
<p>The usual anti-Parkinson's medications are typically either less effective or not effective at all in controlling symptoms; patients may be exquisitely sensitive to neuroleptic medications like <a href="/wiki/Haloperidol" title="Haloperidol">haloperidol</a>. Additionally, the <a href="/wiki/Acetylcholinesterase_inhibitor" title="Acetylcholinesterase inhibitor">cholinesterase inhibiting</a> medications have shown preliminary efficacy in treating the cognitive, psychiatric, and behavioral aspects of the disease, so correct differential diagnosis is important.</p>
<p><a href="/wiki/Essential_tremor" title="Essential tremor">Essential tremor</a> may be mistaken for Parkinson's disease but lacks all other features besides tremor, and has particular characteristics distinguishing it from Parkinson's, such as improvement with <a href="/wiki/Beta_blocker" title="Beta blocker">beta blockers</a> and <a href="/wiki/Alcoholic_beverage" title="Alcoholic beverage">alcoholic beverages</a>.<sup id="cite_ref-Jankovic2008_0-1" class="reference"><a href="#cite_note-Jankovic2008-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p><a href="/wiki/Wilson%27s_disease" title="Wilson's disease">Wilson's disease</a> (hereditary copper accumulation) may present with parkinsonian features; young patients presenting with parkinsonism or any other movement disorder are frequently screened for this rare condition, because it may respond to medical treatment. Typical tests are <a href="/wiki/Liver_enzymes" title="Liver enzymes" class="mw-redirect">liver function</a>, slit lamp examination for <a href="/wiki/Kayser-Fleischer_ring" title="Kayser-Fleischer ring">Kayser-Fleischer rings</a>, and serum <a href="/wiki/Ceruloplasmin" title="Ceruloplasmin">ceruloplasmin</a> levels.</p>
<p><a name="Signs_and_symptoms" id="Signs_and_symptoms"></a></p>
<h2><span class="mw-headline">Signs and symptoms</span></h2>
<p>Parkinson disease affects movement (motor symptoms). Other typical symptoms include disorders of mood, behavior, thinking, and sensation (non-motor symptoms). Patients' individual symptoms may be quite dissimilar and progression of the disease is also distinctly individual.</p>
<p><a name="Motor_symptoms" id="Motor_symptoms"></a></p>
<h3><span class="mw-headline">Motor symptoms</span></h3>
<p>The <a href="/wiki/Cardinal_symptom" title="Cardinal symptom" class="mw-redirect">cardinal symptoms</a> are (mnemonic "TRAP"):<sup id="cite_ref-Jankovic2008_0-2" class="reference"><a href="#cite_note-Jankovic2008-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<ul>
<li><i><a href="/wiki/Tremor" title="Tremor">Tremor</a></i>: normally 4–6 <a href="/wiki/Hertz" title="Hertz">Hz</a> tremor, maximal when the limb is at rest, and decreased with voluntary movement. It is typically unilateral at onset. This is the most apparent and well-known symptom, though an estimated 30% of patients have little perceptible tremor; these are classified as akinetic-rigid.</li>
<li><i><a href="/wiki/Spasticity" title="Spasticity">Rigidity</a></i>: stiffness; increased muscle tone. In combination with a resting tremor, this produces a ratchety, "cogwheel" rigidity when the limb is passively moved.</li>
<li><i><a href="/wiki/Akinesia" title="Akinesia">Akinesia</a>/<a href="/wiki/Bradykinesia" title="Bradykinesia">bradykinesia</a></i>: absence of movement and slowness, respectively. Rapid, repetitive movements produce a <a href="/wiki/Rhythm" title="Rhythm">dysrhythmic</a> and decremental loss of <a href="/wiki/Amplitude" title="Amplitude">amplitude</a>.</li>
<li><i><a href="/wiki/Postural_instability" title="Postural instability" class="mw-redirect">Postural instability</a></i>: failure of postural <a href="/wiki/Reflexes" title="Reflexes" class="mw-redirect">reflexes</a>, which leads to impaired balance and falls.</li>
</ul>
<p>Other motor symptoms include:</p>
<ul>
<li><a href="/wiki/Gait" title="Gait">Gait</a> and posture disturbances:
<ul>
<li>Shuffling: gait is characterized by short steps, with feet barely leaving the ground, producing an audible shuffling noise. Small obstacles tend to cause the patient to trip.</li>
<li>Decreased arm-swing.</li>
<li>Turning "en bloc": rather than the usual twisting of the neck and trunk and pivoting on the toes, PD patients keep their neck and trunk rigid, requiring multiple small steps to accomplish a turn.</li>
<li>Stooped, forward-flexed posture. In severe forms, the head and upper shoulders may be bent at a <a href="/wiki/Right_angle" title="Right angle">right angle</a> relative to the trunk (camptocormia). <sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup></li>
<li>Festination: a combination of stooped posture, imbalance, and short steps. It leads to a gait that gets progressively faster and faster, often ending in a fall.</li>
<li>Gait freezing: "freezing" is a manifestation of akinesia (an inability to move). Gait freezing is characterized by an inability to move the feet which may worsen in tight, cluttered spaces or when attempting to initiate gait.</li>
<li><a href="/wiki/Dystonia" title="Dystonia">Dystonia</a> (in about 20% of cases): abnormal, sustained, painful twisting muscle contractions, often affecting the foot and ankle (mainly toe flexion and foot inversion) which often interferes with gait.</li>
</ul>
</li>
<li>Speech and swallowing disturbances.
<ul>
<li>Hypophonia: soft speech. Speech quality tends to be soft, hoarse, and monotonous. Some people with Parkinson's disease claim that their tongue is "heavy" or have <a href="/wiki/Cluttered_speech" title="Cluttered speech">cluttered speech</a>.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup></li>
<li>Monotonic speech.</li>
<li>Festinating speech: excessively rapid, soft, poorly-intelligible speech.</li>
<li><a href="/wiki/Drooling" title="Drooling">Drooling</a>: most likely caused by a weak, infrequent swallow and stooped posture.</li>
<li><a href="/wiki/Dysphagia" title="Dysphagia">Dysphagia</a>: impaired ability to swallow. Can lead to <a href="/wiki/Aspiration_pneumonia" title="Aspiration pneumonia">aspiration pneumonia</a>.</li>
</ul>
</li>
<li>Other motor symptoms:
<ul>
<li><a href="/wiki/Fatigue_(physical)" title="Fatigue (physical)" class="mw-redirect">Fatigue</a> (up to 50% of cases);</li>
<li>Masked faces (a mask-like face also known as <a href="/wiki/Hypomimia" title="Hypomimia">hypomimia</a>), with infrequent <a href="/wiki/Blinking" title="Blinking" class="mw-redirect">blinking</a>;<sup id="cite_ref-4" class="reference"><a href="#cite_note-4" title=""><span>[</span>5<span>]</span></a></sup></li>
<li>Difficulty rolling in bed or rising from a seated position;</li>
<li><a href="/wiki/Micrographia_(handwriting)" title="Micrographia (handwriting)">Micrographia</a> (small, cramped handwriting);</li>
<li>Impaired fine motor dexterity and <a href="/wiki/Motor_coordination" title="Motor coordination">motor coordination</a>;</li>
<li>Impaired gross motor coordination;</li>
<li><a href="/wiki/Akathisia" title="Akathisia">Akathisia</a>, the inability to sit still.</li>
</ul>
</li>
</ul>
<p><a name="Neuropsychiatric" id="Neuropsychiatric"></a></p>
<h3><span class="mw-headline">Neuropsychiatric</span></h3>
<p>PD causes cognitive and mood disturbances, being in many cases related.</p>
<p>Estimated prevalence rates of depression vary widely according to the population sampled and methodology used. Reviews of <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">depression</a> estimate its occurrence in anywhere from 20–80% of cases.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup> Estimates from community samples tend to find lower rates than from specialist centres. Most studies use self-report questionnaires such as the <a href="/wiki/Beck_Depression_Inventory" title="Beck Depression Inventory">Beck Depression Inventory</a>, which may overinflate scores due to physical symptoms. Studies using diagnostic interviews by trained psychiatrists also report lower rates of depression. More generally, there is an increased risk for any individual with depression to go on to develop Parkinson's disease at a later date.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup> Seventy percent of individuals with Parkinson's disease diagnosed with pre-existing depression go on to develop anxiety. Ninety percent of Parkinson's disease patients with pre-existing anxiety subsequently develop depression; <a href="/wiki/Apathy" title="Apathy">apathy</a> or <a href="/wiki/Abulia" title="Abulia" class="mw-redirect">abulia</a>.</p>
<p>Cognitive disturbances include:</p>
<ul>
<li><a href="/w/index.php?title=Slowed_reaction_time&amp;action=edit&amp;redlink=1" class="new" title="Slowed reaction time (page does not exist)">Slowed reaction time</a>; both voluntary and involuntary motor responses are significantly slowed.</li>
<li><a href="/wiki/Executive_dysfunction" title="Executive dysfunction" class="mw-redirect">Executive dysfunction</a>, characterized by difficulties in: differential allocation of attention, impulse control, set shifting, prioritizing, evaluating the salience of ambient data, interpreting social cues, and subjective time awareness. This complex is present to some degree in most Parkinson's patients; it may progress to:</li>
<li><a href="/wiki/Dementia" title="Dementia">Dementia</a>: a later development in approximately 20-40% of all patients, typically starting with slowing of thought and progressing to difficulties with abstract thought, memory, and behavioral regulation. <a href="/wiki/Hallucinations" title="Hallucinations" class="mw-redirect">Hallucinations</a>, <a href="/wiki/Delusions" title="Delusions" class="mw-redirect">delusions</a> and <a href="/wiki/Paranoia" title="Paranoia">paranoia</a> may develop.</li>
<li>Short term <a href="/wiki/Memory_loss" title="Memory loss">memory loss</a>; <a href="/wiki/Procedural_memory" title="Procedural memory">procedural memory</a> is more impaired than <a href="/wiki/Declarative_memory" title="Declarative memory">declarative memory</a>. Prompting elicits improved recall.</li>
<li>Non-motor causes of speech/language disturbance in both expressive and receptive language: these include decreased verbal fluency and cognitive disturbance especially related to comprehension of emotional content of speech and of facial expression.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7" title=""><span>[</span>8<span>]</span></a></sup></li>
<li>Medication effects: some of the above cognitive disturbances are improved by dopaminergic medications, while others are actually worsened.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup></li>
</ul>
<p><a name="Sleep" id="Sleep"></a></p>
<h3><span class="mw-headline">Sleep</span></h3>
<ul>
<li>Excessive daytime <a href="/wiki/Somnolence" title="Somnolence">somnolence</a></li>
<li>Initial, intermediate, and terminal <a href="/wiki/Insomnia" title="Insomnia">insomnia</a></li>
<li>Disturbances in <a href="/wiki/Rapid_eye_movement_sleep" title="Rapid eye movement sleep">REM</a> sleep: disturbingly vivid dreams, and REM Sleep Disorder, characterized by acting out of dream content—can occur years prior to diagnosis</li>
</ul>
<p><a name="Perception" id="Perception"></a></p>
<h3><span class="mw-headline">Perception</span></h3>
<ul>
<li>Impaired visual <a href="/wiki/Contrast_sensitivity" title="Contrast sensitivity" class="mw-redirect">contrast sensitivity</a>, spatial reasoning, <a href="/wiki/Color" title="Color">color</a> discrimination, <a href="/wiki/Convergence_insufficiency" title="Convergence insufficiency">convergence insufficiency</a> (characterized by <a href="/wiki/Double_vision" title="Double vision">double vision</a>) and <a href="/wiki/Oculomotor_control" title="Oculomotor control" class="mw-redirect">oculomotor control</a></li>
<li><a href="/wiki/Dizziness" title="Dizziness">Dizziness</a> and fainting; usually attributable <a href="/wiki/Orthostatic_hypotension" title="Orthostatic hypotension">orthostatic hypotension</a>, a failure of the <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic nervous system</a> to adjust blood pressure in response to changes in body position</li>
<li>Impaired <a href="/wiki/Proprioception" title="Proprioception">proprioception</a> (the awareness of bodily position in three-dimensional space)</li>
<li>Reduction or loss of sense of <a href="/wiki/Olfaction" title="Olfaction">smell</a> (<a href="/wiki/Hyposmia" title="Hyposmia">hyposmia</a> or <a href="/wiki/Anosmia" title="Anosmia">anosmia</a>) - can occur years prior to diagnosis</li>
<li><a href="/wiki/Pain" title="Pain">pain</a>: neuropathic, muscle, joints, and tendons, attributable to tension, dystonia, rigidity, joint stiffness, and injuries associated with attempts at accommodation</li>
</ul>
<p><a name="Autonomic" id="Autonomic"></a></p>
<h3><span class="mw-headline">Autonomic</span></h3>
<ul>
<li>Oily skin and <a href="/wiki/Seborrheic_dermatitis" title="Seborrheic dermatitis" class="mw-redirect">seborrheic dermatitis</a><sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup></li>
<li><a href="/wiki/Urinary_incontinence" title="Urinary incontinence">Urinary incontinence</a>, typically in later disease progression</li>
<li><a href="/wiki/Nocturia" title="Nocturia">Nocturia</a> (getting up in the night to pass urine)—up to 60% of cases</li>
<li><a href="/wiki/Constipation" title="Constipation">Constipation</a> and <a href="/wiki/Gastric" title="Gastric" class="mw-redirect">gastric</a> dysmotility that is severe enough to endanger comfort and even health</li>
<li>Altered sexual function: characterized by profound impairment of sexual arousal, behavior, orgasm, and drive is found in mid and late Parkinson disease. Current data addresses male sexual function almost exclusively.</li>
<li><a href="/wiki/Weight_loss" title="Weight loss">Weight loss</a>, which is significant over a period of ten years.</li>
</ul>
<p><a name="Causes" id="Causes"></a></p>
<h2><span class="mw-headline">Causes</span></h2>
<p>Most people with Parkinson's disease are described as having <a href="/wiki/Idiopathic" title="Idiopathic">idiopathic</a> Parkinson's disease (having no specific known cause). There are far less common causes of Parkinson's disease including genetic, toxins, head trauma, cerebral <a href="/wiki/Hypoxia_(medical)" title="Hypoxia (medical)">anoxia</a>, and drug-induced Parkinson's disease.</p>
<p><a name="Genetic" id="Genetic"></a></p>
<h3><span class="mw-headline">Genetic</span></h3>
<p>In recent years, a number of specific genetic mutations causing Parkinson's disease have been discovered, including in certain populations (<a href="/wiki/Contursi" title="Contursi" class="mw-redirect">Contursi</a>, Italy). These account for a small minority of cases of Parkinson's disease. Someone who has Parkinson's disease is more likely to have relatives that also have Parkinson's disease. However, this does not mean that the disorder has been passed on genetically.</p>
<p><a name="Toxins" id="Toxins"></a></p>
<h3><span class="mw-headline">Toxins</span></h3>
<p>One theory holds that the disease may result in many or even most cases from the combination of a genetically determined vulnerability to environmental <a href="/wiki/Toxin" title="Toxin">toxins</a> along with exposure to those toxins.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup> This hypothesis is consistent with the fact that Parkinson's disease is not distributed homogeneously throughout the population; its incidence varies geographically. However, the fact that the first appearance of the syndrome predates the first synthesis of the compounds often attributed to causing Parkinson's disease indicates that these recently synthesized compounds cannot be the sole cause of Parkinsonism. The toxins most strongly suspected at present are certain <a href="/wiki/Pesticide" title="Pesticide">pesticides</a> and transition-series metals such as <a href="/wiki/Manganism" title="Manganism">manganese</a> or iron, especially those that generate <a href="/wiki/Reactive_oxygen_species" title="Reactive oxygen species">reactive oxygen species</a>,<sup id="cite_ref-Jenner1998_11-0" class="reference"><a href="#cite_note-Jenner1998-11" title=""><span>[</span>12<span>]</span></a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12" title=""><span>[</span>13<span>]</span></a></sup> and/or bind to <a href="/wiki/Neuromelanin" title="Neuromelanin" class="mw-redirect">neuromelanin</a>, as originally suggested by G.C. Cotzias.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> In the Cancer Prevention Study II Nutrition Cohort, a longitudinal investigation, individuals who were exposed to pesticides had a 70% higher incidence of PD than individuals who were not exposed.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup></p>
<p>The tragedy of a group of drug addicts in California in the early 1980s who consumed a contaminated and illicitly produced batch of the synthetic opiate <a href="/wiki/MPPP" title="MPPP">MPPP</a> brought to light <a href="/wiki/MPTP" title="MPTP">MPTP</a> (pro-toxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyidine) as a specific cause of Parkinson symptoms. This made it possible to develop the first animal model for Parkinson's. MPTP's toxicity likely comes from the generation of <a href="/wiki/Reactive_oxygen_species" title="Reactive oxygen species">reactive oxygen species</a> through tyrosine hydroxylation.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16" title=""><span>[</span>17<span>]</span></a></sup> <a href="/w/index.php?title=The_Case_of_the_Frozen_Addicts&amp;action=edit&amp;redlink=1" class="new" title="The Case of the Frozen Addicts (page does not exist)">The Case of the Frozen Addicts</a> by <a href="/w/index.php?title=J._William_Langston&amp;action=edit&amp;redlink=1" class="new" title="J. William Langston (page does not exist)">J. William Langston</a> (Vintage, New York, June 25, 1996) documents this tragedy and describes the first attempts at fetal brain tissue transplants to treat PD.</p>
<p>Other toxin-based models employ PCBs,<sup id="cite_ref-17" class="reference"><a href="#cite_note-17" title=""><span>[</span>18<span>]</span></a></sup> <a href="/wiki/Paraquat" title="Paraquat">paraquat</a><sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup> (a herbicide) in combination with maneb (a fungicide),<sup id="cite_ref-19" class="reference"><a href="#cite_note-19" title=""><span>[</span>20<span>]</span></a></sup> <a href="/wiki/Rotenone" title="Rotenone">rotenone</a><sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup> (an insecticide), and specific organochlorine pesticides including dieldrin<sup id="cite_ref-21" class="reference"><a href="#cite_note-21" title=""><span>[</span>22<span>]</span></a></sup> and lindane.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22" title=""><span>[</span>23<span>]</span></a></sup> Rotenone is an inhibitor of complex 1 of the electron transport chain. It easily crosses membranes due to its extremely hydrophobic properties. Rotenone, therefore, does not rely on the dopamine transporter to enter into the cytoplasm. Numerous studies have found an increase in PD in persons who consume rural well water; researchers theorize that water consumption is a proxy measure of pesticide exposure. In agreement with this hypothesis are studies which have found a dose-dependent increase in PD in persons exposed to agricultural chemicals.</p>
<p><a name="Head_trauma" id="Head_trauma"></a></p>
<h3><span class="mw-headline">Head trauma</span></h3>
<p>Past episodes of head trauma are reported more frequently by individuals with Parkinson's disease than by others in the population.<sup id="cite_ref-Bower_23-0" class="reference"><a href="#cite_note-Bower-23" title=""><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup><sup id="cite_ref-Uryu2003_25-0" class="reference"><a href="#cite_note-Uryu2003-25" title=""><span>[</span>26<span>]</span></a></sup> A recent methodologically strong retrospective study<sup id="cite_ref-Bower_23-1" class="reference"><a href="#cite_note-Bower-23" title=""><span>[</span>24<span>]</span></a></sup> found that those who have experienced a head injury are four times more likely to develop Parkinson’s disease than those who have never suffered a head injury. The risk of developing Parkinson’s increases eightfold for patients who have had head trauma requiring hospitalization, and it increases 11-fold for patients who had experienced severe head injury. The authors comment that since head trauma is a rare event, the contribution to PD incidence is slight. They express further concern that their results may be biased by recall, i.e., the PD patients because they reflect upon the causes of their illness, may remember head trauma better than the non-ill control subjects. These limitations were overcome recently by Tanner and colleagues,<sup id="cite_ref-26" class="reference"><a href="#cite_note-26" title=""><span>[</span>27<span>]</span></a></sup> who found a similar risk of 3.8, with increasing risk associated with more severe injury and hospitalization. However, whether the head trauma actually contributed to Parkinson's disease development or the early symptoms of clumsiness associated with Parkinson's causes individuals to have more head trauma is still unknown.</p>
<p><a name="Pathophysiology" id="Pathophysiology"></a></p>
<h2><span class="mw-headline">Pathophysiology</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:252px;"><a href="/wiki/File:DA-loops_in_PD.jpg" class="image" title="Dopaminergic pathways of the human brain in normal condition (left) and Parkinson's disease (right). Red Arrows indicate suppression of the target, blue arrows indicate stimulation of target structure."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/9/94/DA-loops_in_PD.jpg/250px-DA-loops_in_PD.jpg" width="250" height="199" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:DA-loops_in_PD.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Dopaminergic pathways of the human brain in normal condition (left) and Parkinson's disease (right). Red Arrows indicate suppression of the target, blue arrows indicate stimulation of target structure.</div>
</div>
</div>
<p>The symptoms of Parkinson's disease result from the loss of pigmented <a href="/wiki/Dopamine" title="Dopamine">dopamine</a>-secreting (dopaminergic) cells in the <a href="/wiki/Pars_compacta" title="Pars compacta">pars compacta</a> region of the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a> (literally "black substance"). These neurons project to the <a href="/wiki/Striatum" title="Striatum">striatum</a> and their loss leads to alterations in the activity of the neural circuits within the basal ganglia that regulate movement, in essence an inhibition of the <a href="/wiki/Direct_pathway" title="Direct pathway" class="mw-redirect">direct pathway</a> and excitation of the <a href="/wiki/Indirect_pathway" title="Indirect pathway" class="mw-redirect">indirect pathway</a>.</p>
<p>The direct pathway facilitates movement and the indirect pathway inhibits movement, thus the loss of these cells leads to a hypokinetic movement disorder. The lack of <a href="/wiki/Dopamine" title="Dopamine">dopamine</a> results in increased inhibition of the ventral anterior nucleus of the thalamus, which sends excitatory projections to the <a href="/wiki/Motor_cortex" title="Motor cortex">motor cortex</a>, thus leading to <a href="/wiki/Hypokinesia" title="Hypokinesia">hypokinesia</a>.</p>
<p>There are four major dopamine pathways in the brain; the nigrostriatal pathway, referred to above, mediates movement and is the most conspicuously affected in early Parkinson's disease. The other pathways are the mesocortical, the mesolimbic, and the tuberoinfundibular. Disruption of dopamine along the non-striatal pathways likely explains much of the neuropsychiatric pathology associated with Parkinson's disease.</p>
<p>The mechanism by which the brain cells in Parkinson's are lost may consist of an abnormal accumulation of the protein <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a> bound to ubiquitin in the damaged cells. The <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a>-ubiquitin complex cannot be directed to the proteosome. This <a href="/wiki/Protein" title="Protein">protein</a> accumulation forms proteinaceous cytoplasmic inclusions called <a href="/wiki/Lewy_bodies" title="Lewy bodies" class="mw-redirect">Lewy bodies</a>. The latest research on pathogenesis of disease has shown that the death of dopaminergic neurons by alpha-synuclein is due to a defect in the machinery that transports proteins between two major cellular organelles—the endoplasmic reticulum (ER) and the Golgi apparatus. Certain proteins like Rab1 may reverse this defect caused by alpha-synuclein in animal models.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27" title=""><span>[</span>28<span>]</span></a></sup></p>
<p>Excessive accumulations of iron, which are toxic to nerve cells, are also typically observed in conjunction with the protein inclusions. Iron and other <a href="/wiki/Transition_metals" title="Transition metals" class="mw-redirect">transition metals</a> such as copper bind to <a href="/wiki/Neuromelanin" title="Neuromelanin" class="mw-redirect">neuromelanin</a> in the affected neurons of the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a>. <a href="/wiki/Neuromelanin" title="Neuromelanin" class="mw-redirect">Neuromelanin</a> may be acting as a protective agent. The most likely mechanism is generation of <a href="/wiki/Reactive_oxygen_species" title="Reactive oxygen species">reactive oxygen species</a>.<sup id="cite_ref-Jenner1998_11-1" class="reference"><a href="#cite_note-Jenner1998-11" title=""><span>[</span>12<span>]</span></a></sup> Iron also induces aggregation of synuclein by oxidative mechanisms.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28" title=""><span>[</span>29<span>]</span></a></sup> Similarly, dopamine and the byproducts of dopamine production enhance alpha-synuclein aggregation. The precise mechanism whereby such aggregates of alpha-synuclein damage the cells is not known. The aggregates may be merely a normal reaction by the cells as part of their effort to correct a different, as-yet unknown, insult. Based on this mechanistic hypothesis, a <a href="/wiki/Genetically_modified_organism" title="Genetically modified organism">transgenic mouse model</a> of Parkinson's has been generated by introduction of human wild-type alpha-synuclein into the mouse genome under control of the <a href="/wiki/Platelet-derived_growth_factor" title="Platelet-derived growth factor">platelet-derived-growth factor</a>-β promoter.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29" title=""><span>[</span>30<span>]</span></a></sup></p>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="mw-headline">Diagnosis</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:202px;"><a href="/wiki/File:PET_scan_Parkinson%27s_Disease.jpg" class="image" title="18F PET scan shows decreased dopamine activity in the basal ganglia, a pattern which aids in diagnosing Parkinson's disease."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/8/87/PET_scan_Parkinson%27s_Disease.jpg/200px-PET_scan_Parkinson%27s_Disease.jpg" width="200" height="185" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:PET_scan_Parkinson%27s_Disease.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
18F PET scan shows decreased dopamine activity in the <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a>, a pattern which aids in diagnosing Parkinson's disease.</div>
</div>
</div>
<p>Typically, the diagnosis is based on medical history and neurological examination conducted by interviewing and observing the patient in person using the <a href="/wiki/Unified_Parkinson%27s_Disease_Rating_Scale" title="Unified Parkinson's Disease Rating Scale">Unified Parkinson's Disease Rating Scale</a>. A radiotracer for <a href="/wiki/SPECT" title="SPECT" class="mw-redirect">SPECT</a> scanning machines called <a href="/wiki/DaTSCAN" title="DaTSCAN" class="mw-redirect">DaTSCAN</a> and made by <a href="/wiki/General_Electric" title="General Electric">General Electric</a> is specialized for diagnosing Parkinson's Disease, but it is only marketed in Europe. Due to this, the disease can be difficult to diagnose accurately, especially in its early stages. Due to symptom overlap with other diseases, only 75% of clinical diagnoses of PD are confirmed to be idiopathic PD at autopsy.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30" title=""><span>[</span>31<span>]</span></a></sup> Early signs and symptoms of PD may sometimes be dismissed as the effects of normal aging. The physician may need to observe the person for some time until it is apparent that the symptoms are consistently present. Usually doctors look for shuffling of feet and lack of swing in the arms. Doctors may sometimes request brain scans or laboratory tests in order to rule out other diseases. However, CT and MRI brain scans of people with PD usually appear normal.</p>
<p><a href="/wiki/Clinical_practice_guideline" title="Clinical practice guideline" class="mw-redirect">Clinical practice guidelines</a> introduced in the <a href="/wiki/United_Kingdom" title="United Kingdom">UK</a> in 2006 state that the diagnosis and follow-up of Parkinson's disease should be done by a specialist in the disease, usually a <a href="/wiki/Neurology" title="Neurology">neurologist</a> or <a href="/wiki/Geriatrician" title="Geriatrician" class="mw-redirect">geriatrician</a> with an interest in movement disorders.<sup id="cite_ref-nice35_1-1" class="reference"><a href="#cite_note-nice35-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="mw-headline">Treatment</span></h2>
<p>Parkinson's disease is a chronic disorder that requires broad-based management including patient and family education, support group services, general wellness maintenance, <a href="/wiki/Physiotherapy" title="Physiotherapy" class="mw-redirect">physiotherapy</a>, exercise, and nutrition.<sup id="cite_ref-nice35_1-2" class="reference"><a href="#cite_note-nice35-1" title=""><span>[</span>2<span>]</span></a></sup> At present, there is no cure for PD, but medications or surgery can provide relief from the symptoms.</p>
<p><a name="Levodopa" id="Levodopa"></a></p>
<h3><span class="mw-headline">Levodopa</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:252px;"><a href="/wiki/File:Stalevo.jpg" class="image" title="Stalevo for treatment of Parkinson's disease"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/0/09/Stalevo.jpg/250px-Stalevo.jpg" width="250" height="184" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Stalevo.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Stalevo for treatment of Parkinson's disease</div>
</div>
</div>
<p>The most widely used form of treatment is <a href="/wiki/L-dopa" title="L-dopa" class="mw-redirect">L-dopa</a> in various forms. L-dopa is transformed into dopamine in the dopaminergic neurons by L-aromatic amino acid decarboxylase (often known by its former name dopa-decarboxylase). However, only 1-5% of L-dopa enters the dopaminergic neurons. The remaining L-dopa is often metabolised to dopamine elsewhere, causing a wide variety of side effects. Due to feedback inhibition, L-dopa results in a reduction in the endogenous formation of L-dopa, and so eventually becomes counterproductive.</p>
<p><a href="/wiki/Carbidopa" title="Carbidopa">Carbidopa</a> and <a href="/wiki/Benserazide" title="Benserazide">benserazide</a> are dopa decarboxylase inhibitors. They help to prevent the metabolism of L-dopa before it reaches the dopaminergic neurons and are generally given as combination preparations of <a href="/wiki/Carbidopa/levodopa" title="Carbidopa/levodopa">carbidopa/levodopa</a> (co-careldopa) (e.g. Sinemet, Parcopa) and <a href="/wiki/Benserazide" title="Benserazide">benserazide/levodopa</a> (co-beneldopa) (e.g. Madopar). There are also controlled release versions of Sinemet and Madopar that spread out the effect of the L-dopa. Duodopa is a combination of levodopa and carbidopa, dispersed as a viscous gel. Using a patient-operated portable pump, the drug is continuously delivered via a tube directly into the upper small intestine, where it is rapidly absorbed. There is also Stalevo (Carbidopa, Levodopa and Entacapone).</p>
<p><a name="COMT_inhibitors" id="COMT_inhibitors"></a></p>
<h3><span class="mw-headline">COMT inhibitors</span></h3>
<p><a href="/wiki/Tolcapone" title="Tolcapone">Tolcapone</a> inhibits the <a href="/wiki/COMT" title="COMT" class="mw-redirect">COMT</a> enzyme, thereby prolonging the effects of L-dopa, and so has been used to complement L-dopa. However, due to its possible side effects such as liver failure, it is limited in its availability. A similar drug, <a href="/wiki/Entacapone" title="Entacapone">entacapone</a> has not been shown to cause significant alterations of liver function and maintains adequate inhibition of COMT over time.<sup id="cite_ref-TNcilia_31-0" class="reference"><a href="#cite_note-TNcilia-31" title=""><span>[</span>32<span>]</span></a></sup></p>
<p><a name="Dopamine_agonists" id="Dopamine_agonists"></a></p>
<h3><span class="mw-headline">Dopamine agonists</span></h3>
<p>The dopamine agonists <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>, <a href="/wiki/Pramipexole" title="Pramipexole">pramipexole</a>, <a href="/wiki/Ropinirole" title="Ropinirole">ropinirole</a>, <a href="/wiki/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="/wiki/Apomorphine" title="Apomorphine">apomorphine</a>, and <a href="/wiki/Lisuride" title="Lisuride">lisuride</a> are moderately effective. These have their own side effects including those listed above in addition to somnolence, hallucinations and/or insomnia. Several forms of dopamine agonism have been linked with a markedly increased risk of problem gambling. Dopamine agonists initially act by stimulating some of the dopamine receptors. However, they cause the dopamine receptors to become progressively less sensitive, thereby eventually increasing the symptoms.</p>
<p>Dopamine agonists can be useful for patients experiencing on-off fluctuations and dyskinesias as a result of high doses of L-dopa. Apomorphine can be administered via subcutaneous injection using a small pump which is carried by the patient. A low dose is automatically administered throughout the day, reducing the fluctuations of motor symptoms by providing a steady dose of dopaminergic stimulation. After an initial "apomorphine challenge" in hospital to test its effectiveness and brief patient and <a href="/wiki/Primary_caregiver" title="Primary caregiver">primary caregiver</a> (often a spouse or partner), the latter of whom takes over maintenance of the pump. The injection site must be changed daily and rotated around the body to avoid the formation of <a href="/wiki/Nodule_(medicine)" title="Nodule (medicine)">nodules</a>. Apomorphine is also available in a more acute dose as an <a href="/wiki/Autoinjector" title="Autoinjector">autoinjector</a> pen for emergency doses such as after a fall or first thing in the morning. Nausea and vomiting are common, and may require <a href="/wiki/Domperidone" title="Domperidone">domperidone</a> (an antiemetic).</p>
<p><a name="MAO-B_inhibitors" id="MAO-B_inhibitors"></a></p>
<h3><span class="mw-headline">MAO-B inhibitors</span></h3>
<p><a href="/wiki/Selegiline" title="Selegiline">Selegiline</a> and <a href="/wiki/Rasagiline" title="Rasagiline">rasagiline</a> reduce the symptoms by inhibiting monoamine oxidase-B (MAO-B), thereby inhibiting the breakdown of dopamine secreted by the dopaminergic neurons. Metabolites of selegiline include levoamphetamine and <a href="/wiki/Levomethamphetamine" title="Levomethamphetamine">levomethamphetamine</a>. This might result in side effects such as insomnia. A side effect of selegiline in conjunction with L-dopa can be <a href="/wiki/Stomatitis" title="Stomatitis">stomatitis</a>. One report raised concern about increased mortality when MAO-B inhibitors were combined with L-dopa;<sup id="cite_ref-32" class="reference"><a href="#cite_note-32" title=""><span>[</span>33<span>]</span></a></sup> however subsequent studies have not confirmed this finding.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33" title=""><span>[</span>34<span>]</span></a></sup> In contrast to non-selective <a href="/wiki/Monoamine_oxidase_inhibitors" title="Monoamine oxidase inhibitors" class="mw-redirect">monoamine oxidase inhibitors</a>, tyramine-containing foods do not cause a hypertensive crisis.</p>
<p><a name="Surgery_and_deep_brain_stimulation" id="Surgery_and_deep_brain_stimulation"></a></p>
<h3><span class="mw-headline">Surgery and deep brain stimulation</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:202px;"><a href="/wiki/File:Parkinson_surgery.jpg" class="image" title="Photograph showing an electrode being inserted during deep brain stimulation"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/9/91/Parkinson_surgery.jpg/200px-Parkinson_surgery.jpg" width="200" height="298" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Parkinson_surgery.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Photograph showing an electrode being inserted during deep brain stimulation</div>
</div>
</div>
<p>Treating Parkinson's disease with surgery was once a common practice, but after the discovery of levodopa, surgery was restricted to only a few cases. Studies in the past few decades have led to great improvements in surgical techniques, and surgery is again being used in people with advanced PD for whom drug therapy is no longer sufficient.</p>
<p><a href="/wiki/Deep_brain_stimulation" title="Deep brain stimulation">Deep brain stimulation</a> is presently the most used surgical means of treatment, but other surgical therapies that have shown promise include surgical lesion of the <a href="/wiki/Subthalamic_nucleus" title="Subthalamic nucleus">subthalamic nucleus</a><sup id="cite_ref-34" class="reference"><a href="#cite_note-34" title=""><span>[</span>35<span>]</span></a></sup> and of the internal segment of the <a href="/wiki/Globus_pallidus" title="Globus pallidus">globus pallidus</a>, a procedure known as <a href="/wiki/Pallidotomy" title="Pallidotomy">pallidotomy</a>.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35" title=""><span>[</span>36<span>]</span></a></sup></p>
<p><a name="Neurorehabilitation" id="Neurorehabilitation"></a></p>
<h3><span class="mw-headline">Neurorehabilitation</span></h3>
<p>There is partial evidence that speech or mobility problems can improve with rehabilitation although studies are still scarce and of low quality.<sup id="cite_ref-pmid11687029_36-0" class="reference"><a href="#cite_note-pmid11687029-36" title=""><span>[</span>37<span>]</span></a></sup><sup id="cite_ref-pmid11406045_37-0" class="reference"><a href="#cite_note-pmid11406045-37" title=""><span>[</span>38<span>]</span></a></sup><sup id="cite_ref-pmid18181210_38-0" class="reference"><a href="#cite_note-pmid18181210-38" title=""><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-pmid12132992_39-0" class="reference"><a href="#cite_note-pmid12132992-39" title=""><span>[</span>40<span>]</span></a></sup> Regular physical exercise and/or therapy can be beneficial to the patient for maintaining and improving mobility, flexibility, strength, gait speed, and quality of life;<sup id="cite_ref-pmid18181210_38-1" class="reference"><a href="#cite_note-pmid18181210-38" title=""><span>[</span>39<span>]</span></a></sup> and speech therapy may improve voice and speech function.<sup id="cite_ref-pmid12132992_39-1" class="reference"><a href="#cite_note-pmid12132992-39" title=""><span>[</span>40<span>]</span></a></sup> One of the most widely practiced treatment for the speech disorders associated with Parkinson's disease is the <a href="/w/index.php?title=Lee_Silverman_Voice_Treatment&amp;action=edit&amp;redlink=1" class="new" title="Lee Silverman Voice Treatment (page does not exist)">Lee Silverman Voice Treatment</a> (LSVT). LSVT focuses on increasing vocal loudness.<sup id="cite_ref-pmid17117354_40-0" class="reference"><a href="#cite_note-pmid17117354-40" title=""><span>[</span>41<span>]</span></a></sup></p>
<p><a name="Prognosis" id="Prognosis"></a></p>
<h2><span class="mw-headline">Prognosis</span></h2>
<p>PD is not considered to be a fatal disease by itself, but it progresses with time. The average life expectancy of a PD patient is generally lower than for people who do not have the disease.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup> In the late stages of the disease, PD may cause complications such as choking, pneumonia, and falls that can lead to death.</p>
<p>The progression of symptoms in PD may take 20 years or more to be fatal. In some people, however, the disease progresses more quickly. There is no way to predict what course the disease will take for an individual person. With appropriate treatment, most people with PD can live productive lives for many years after diagnosis.</p>
<p>In at least some studies, it has been observed that mortality was significantly increased, and longevity decreased among nursing home patients as compared with community dwelling patients.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42" title=""><span>[</span>43<span>]</span></a></sup></p>
<p>One commonly used system for describing how the symptoms of PD progress is called the <a href="/wiki/Hoehn_and_Yahr_scale" title="Hoehn and Yahr scale">Hoehn and Yahr scale</a>. Another commonly used scale is the <a href="/wiki/Unified_Parkinson%27s_Disease_Rating_Scale" title="Unified Parkinson's Disease Rating Scale">Unified Parkinson's Disease Rating Scale</a> (UPDRS). This much more complicated scale has multiple ratings that measure motor function, and also mental functioning, behavior, mood, and activities of daily living. Both the Hoehn and Yahr scale and the UPDRS are used to measure how individuals are faring and how much treatments are helping them. It should be noted that neither scale is specific to Parkinson's disease; that patients with other illnesses can score in the Parkinson's range.</p>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2><span class="mw-headline">Epidemiology</span></h2>
<p>According to some sources, Parkinsons disease is slightly less prevalent in the <a href="/wiki/African-American" title="African-American" class="mw-redirect">African-American</a> community. The average crude prevalence is estimated at being from 120-180 out of 100,000 among the <a href="/wiki/Caucasian_race" title="Caucasian race">Caucasian</a> (white) community.<sup id="cite_ref-holisticonline.com_43-0" class="reference"><a href="#cite_note-holisticonline.com-43" title=""><span>[</span>44<span>]</span></a></sup> The <a href="/wiki/Parsi_people" title="Parsi people" class="mw-redirect">Parsi</a> community in <a href="/wiki/Mumbai" title="Mumbai">Mumbai</a>, <a href="/wiki/India" title="India">India</a> suffers from particularly high rates of Parkinson's disease.<sup id="cite_ref-holisticonline.com_43-1" class="reference"><a href="#cite_note-holisticonline.com-43" title=""><span>[</span>44<span>]</span></a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44" title=""><span>[</span>45<span>]</span></a></sup></p>
<p><a name="History" id="History"></a></p>
<h2><span class="mw-headline">History</span></h2>
<p>Symptoms of Parkinson's disease have been known and treated since medieval times, most notably by <a href="/wiki/Averroes" title="Averroes">Averroes</a>.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45" title=""><span>[</span>46<span>]</span></a></sup> However, it was not formally recognized and its symptoms were not documented until 1817 in <i>An Essay on the Shaking Palsy</i><sup id="cite_ref-46" class="reference"><a href="#cite_note-46" title=""><span>[</span>47<span>]</span></a></sup> by the British physician <a href="/wiki/James_Parkinson" title="James Parkinson">James Parkinson</a>. Parkinson's disease was then known as <i>paralysis agitans</i>, the term "Parkinson's disease" being coined later by <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>. The underlying <a href="/wiki/Biochemical" title="Biochemical" class="mw-redirect">biochemical</a> changes in the <a href="/wiki/Brain" title="Brain">brain</a> were identified in the 1950s due largely to the work of Swedish scientist <a href="/wiki/Arvid_Carlsson" title="Arvid Carlsson">Arvid Carlsson</a>, who later went on to win a <a href="/wiki/Nobel_Prize" title="Nobel Prize">Nobel Prize</a>. <a href="/wiki/L-dopa" title="L-dopa" class="mw-redirect">L-dopa</a> entered clinical practice in 1967,<sup id="cite_ref-47" class="reference"><a href="#cite_note-47" title=""><span>[</span>48<span>]</span></a></sup> and the first large study reporting improvements in patients with Parkinson's disease resulting from treatment with L-dopa was published in 1968.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48" title=""><span>[</span>49<span>]</span></a></sup></p>
<p><a name="Research_directions" id="Research_directions"></a></p>
<h2><span class="mw-headline">Research directions</span></h2>
<p><a name="Gene_therapy" id="Gene_therapy"></a></p>
<h3><span class="mw-headline">Gene therapy</span></h3>
<p>Currently under investigation is gene therapy. This involves using a non-infectious virus to shuttle a gene into a part of the brain called the subthalamic nucleus (STN). The gene used leads to the production of an enzyme called glutamic acid decarboxylase (<a href="/wiki/Glutamate_decarboxylase" title="Glutamate decarboxylase">GAD</a>), which catalyses the production of a <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> called <a href="/wiki/GABA" title="GABA" class="mw-redirect">GABA</a>.<sup id="cite_ref-pmid17586305_49-0" class="reference"><a href="#cite_note-pmid17586305-49" title=""><span>[</span>50<span>]</span></a></sup> GABA acts as a direct inhibitor on the overactive cells in the STN.</p>
<p><a href="/wiki/GDNF" title="GDNF" class="mw-redirect">GDNF</a> infusion involves the infusion of GDNF (glial-derived neurotrophic factor) into the basal ganglia using surgically implanted catheters. Via a series of biochemical reactions, GDNF stimulates the formation of L-dopa. GDNF therapy is still in development.</p>
<p>Implantation of stem cells genetically engineered to produce dopamine or stem cells that transform into dopamine-producing cells has already started being used. These could not constitute cures because they do not address the considerable loss of activity of the dopaminergic neurons. Initial results have been unsatisfactory, with patients still retaining their drugs and symptoms.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since April 2009" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a name="Neuroprotective_agents" id="Neuroprotective_agents"></a></p>
<h3><span class="mw-headline">Neuroprotective agents</span></h3>
<p><a href="/wiki/Neuroprotective" title="Neuroprotective" class="mw-redirect">Neuroprotective</a> treatments are at the forefront of PD research, but are still under clinical scrutiny.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50" title=""><span>[</span>51<span>]</span></a></sup> These agents could protect neurons from cell death induced by disease presence resulting in a slower progression of disease. Agents currently under investigation as neuroprotective agents include anti-apoptotic drugs (CEP 1347 and CTCT346), lazaroids, bioenergetics, antiglutamatergic agents and dopamine receptors.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51" title=""><span>[</span>52<span>]</span></a></sup> Clinically evaluated neuroprotective agents are the monoamine oxidase B inhibitors selegiline<sup id="cite_ref-PSG_1993_52-0" class="reference"><a href="#cite_note-PSG_1993-52" title=""><span>[</span>53<span>]</span></a></sup> and rasagiline, dopamine agonists, and the complex I mitochondrial fortifier <a href="/wiki/Coenzyme_Q10" title="Coenzyme Q10">coenzyme Q10</a>. Alpha6beta2 <a href="/wiki/NAChR" title="NAChR" class="mw-redirect">nAChR</a> may represent a relevant target for PD therapeutics.<sup id="cite_ref-pmid17631864_53-0" class="reference"><a href="#cite_note-pmid17631864-53" title=""><span>[</span>54<span>]</span></a></sup></p>
<p><a name="Neural_transplantation" id="Neural_transplantation"></a></p>
<h3><span class="mw-headline">Neural transplantation</span></h3>
<p>The first prospective randomised <a href="/wiki/Blind_experiment" title="Blind experiment">double-blind</a> <a href="/wiki/Placebo-controlled_studies" title="Placebo-controlled studies">sham-placebo</a> controlled trial of dopamine-producing cell transplants failed to show an improvement in quality of life although some significant clinical improvements were seen in patients below the age of 60.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54" title=""><span>[</span>55<span>]</span></a></sup> A significant problem was the excess release of dopamine by the transplanted tissue, leading to <a href="/wiki/Dystonia" title="Dystonia">dystonias</a>.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55" title=""><span>[</span>56<span>]</span></a></sup> Research in African <a href="/wiki/Green_monkey" title="Green monkey" class="mw-redirect">green monkeys</a> suggests that the use of <a href="/wiki/Stem_cell" title="Stem cell">stem cells</a> might in future provide a similar benefit without inducing dystonias.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56" title=""><span>[</span>57<span>]</span></a></sup></p>
<p><a name="Complementary_therapies" id="Complementary_therapies"></a></p>
<h3><span class="mw-headline">Complementary therapies</span></h3>
<p>Nutrients have been used in clinical studies and are used by people with PD in order to partially treat PD or slow down its deterioration. The L-dopa precursor <a href="/wiki/L-tyrosine" title="L-tyrosine" class="mw-redirect">L-tyrosine</a> was shown to relieve an average of 70% of symptoms.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57" title=""><span>[</span>58<span>]</span></a></sup> Ferrous iron, the essential cofactor for L-dopa biosynthesis was shown to relieve between 10% and 60% of symptoms in 110 out of 110 patients.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58" title=""><span>[</span>59<span>]</span></a></sup> <sup id="cite_ref-59" class="reference"><a href="#cite_note-59" title=""><span>[</span>60<span>]</span></a></sup> More limited efficacy has been obtained with the use of THFA, NADH, and pyridoxine—coenzymes and coenzyme precursors involved in dopamine biosynthesis.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60" title=""><span>[</span>61<span>]</span></a></sup> Vitamin C and vitamin E in large doses are commonly used by patients in order to theoretically lessen the cell damage that occurs in PD. This is because the enzymes superoxide dismutase and catalase require these vitamins in order to nullify the superoxide anion, a toxin commonly produced in damaged cells. However, in the randomized controlled trial, DATATOP of patients with early PD, no beneficial effect for vitamin E compared to placebo was seen.<sup id="cite_ref-PSG_1993_52-1" class="reference"><a href="#cite_note-PSG_1993-52" title=""><span>[</span>53<span>]</span></a></sup> Coenzyme Q10 has more recently been used for similar reasons. MitoQ is a newly developed synthetic substance that is similar in structure and function to coenzyme Q10.</p>
<p><i>Mucuna pruriens</i> is plant of the legume family that has been used by Ayurvedic practitioners to treat Parkinson's for more than 4,500 years; Western medicine is now accepting mucuna as an alternative treatment to, or complementary therapy with, L-dopa, as study after study is proving its effectiveness. Research cited by the <a href="/w/index.php?title=National_Parkinson_Foundation&amp;action=edit&amp;redlink=1" class="new" title="National Parkinson Foundation (page does not exist)">National Parkinson Foundation</a> found that "dose for dose, mucuna was two to three times more effective than equivalent amounts of synthetic L-dopa [and] [t]he side effects were minimal.... Further, the cost of the drug was much cheaper compared to the synthetic drugs." <sup id="cite_ref-61" class="reference"><a href="#cite_note-61" title=""><span>[</span>62<span>]</span></a></sup><sup id="cite_ref-62" class="reference"><a href="#cite_note-62" title=""><span>[</span>63<span>]</span></a></sup></p>
<p>Studies looking at <a href="/wiki/Qigong" title="Qigong">qigong</a> in PD have not reached consensus on its efficacy.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63" title=""><span>[</span>64<span>]</span></a></sup><sup id="cite_ref-64" class="reference"><a href="#cite_note-64" title=""><span>[</span>65<span>]</span></a></sup></p>
<p><a name="Famous_sufferers" id="Famous_sufferers"></a></p>
<h2><span class="mw-headline">Famous sufferers</span></h2>
<table class="metadata plainlinks ambox ambox-content" style="">
<tr>
<td class="mbox-image">
<div style="width: 52px;"><a href="/wiki/File:Ambox_content.png" class="image" title="Ambox content.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png" width="40" height="40" border="0" /></a></div>
</td>
<td class="mbox-text" style="">This article <b>is missing <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">citations</a> or needs <a href="/wiki/Wikipedia:Footnotes" title="Wikipedia:Footnotes">footnotes</a></b>. Please help add <a href="/wiki/Wikipedia:Inline_citations" title="Wikipedia:Inline citations" class="mw-redirect">inline citations</a> to guard against copyright violations and factual inaccuracies. <small><i>(August 2008)</i></small></td>
</tr>
</table>
<table class="metadata plainlinks ambox ambox-style" style="">
<tr>
<td class="mbox-image">
<div style="width: 52px;"><a href="/wiki/File:Ambox_style.png" class="image" title="Ambox style.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/d/d6/Ambox_style.png" width="40" height="40" border="0" /></a></div>
</td>
<td class="mbox-text" style=""><b><a href="/wiki/Wikipedia:Trivia_sections" title="Wikipedia:Trivia sections">Lists of miscellaneous information</a> should be avoided.</b> Please <a href="/wiki/Wikipedia:Handling_trivia#Recommendations_for_handling_trivia" title="Wikipedia:Handling trivia">relocate</a> any relevant information into appropriate sections or articles. <small><i>(August 2008)</i></small></td>
</tr>
</table>
<div class="rellink boilerplate further">Further information: <a href="/wiki/Category:People_with_Parkinson%27s_disease" title="Category:People with Parkinson's disease">People with Parkinson's disease</a></div>
<p>One famous sufferer of young-onset Parkinson's is <a href="/wiki/Michael_J._Fox" title="Michael J. Fox">Michael J. Fox</a>, whose book, <i>Lucky Man</i> (2000), focused on his experiences with the disease and his career and family travails in the midst of it. Fox established <a href="/wiki/The_Michael_J._Fox_Foundation" title="The Michael J. Fox Foundation">The Michael J. Fox Foundation for Parkinson's Research</a> to develop a cure for Parkinson's disease within this decade.</p>
<p>Another foundation that supports Parkinson's research was established by <a href="/wiki/Davis_Phinney" title="Davis Phinney">Davis Phinney</a>, a notable figure in the cycling world. Phinney has competed in the Olympics, Pan-Am Games and has competed as a pro-cyclist for nearly twenty years. The <a href="/wiki/Davis_Phinney_Foundation" title="Davis Phinney Foundation" class="mw-redirect">Davis Phinney Foundation</a> strives to improve the lives of those living with Parkinson's disease.</p>
<p>Other famous sufferers include <a href="/wiki/Pope_John_Paul_II" title="Pope John Paul II">Pope John Paul II</a>, playwright <a href="/wiki/Eugene_O%27Neill" title="Eugene O'Neill">Eugene O'Neill</a>, artist <a href="/wiki/Salvador_Dal%C3%AD" title="Salvador Dalí">Salvador Dalí</a>, evangelist <a href="/wiki/Billy_Graham" title="Billy Graham">Billy Graham</a>, boxer <a href="/wiki/Muhammad_Ali" title="Muhammad Ali">Muhammad Ali</a>, electric guitar pioneer <a href="/wiki/Leo_Fender" title="Leo Fender">Leo Fender</a>, and former US Attorney General <a href="/wiki/Janet_Reno" title="Janet Reno">Janet Reno</a>. Political figures suffering from it have included <a href="/wiki/Francisco_Franco" title="Francisco Franco">Francisco Franco</a>, <a href="/wiki/Booth_Gardner" title="Booth Gardner">Booth Gardner</a>, <a href="/wiki/Deng_Xiaoping" title="Deng Xiaoping">Deng Xiaoping</a> and <a href="/wiki/Mao_Zedong" title="Mao Zedong">Mao Zedong</a>, and former Prime Minister of Canada <a href="/wiki/Pierre_Trudeau" title="Pierre Trudeau">Pierre Trudeau</a>. Numerous actors have also been afflicted with Parkinson's such as: <a href="/wiki/Terry-Thomas" title="Terry-Thomas">Terry-Thomas</a>, <a href="/wiki/Deborah_Kerr" title="Deborah Kerr">Deborah Kerr</a>, <a href="/wiki/Kenneth_More" title="Kenneth More">Kenneth More</a>, <a href="/wiki/Vincent_Price" title="Vincent Price">Vincent Price</a>, <a href="/wiki/Jim_Backus" title="Jim Backus">Jim Backus</a> and <a href="/wiki/Michael_Redgrave" title="Michael Redgrave">Michael Redgrave</a>. <a href="/wiki/Helen_Beardsley" title="Helen Beardsley">Helen Beardsley</a> (of <i><a href="/wiki/Yours,_Mine_and_Ours_(1968_film)" title="Yours, Mine and Ours (1968 film)">Yours, Mine and Ours</a></i> fame) also suffered from this disease toward the end of her life. Director <a href="/wiki/George_Roy_Hill" title="George Roy Hill">George Roy Hill</a> (<i><a href="/wiki/The_Sting" title="The Sting">The Sting</a></i>, <i><a href="/wiki/Butch_Cassidy_and_the_Sundance_Kid" title="Butch Cassidy and the Sundance Kid">Butch Cassidy and the Sundance Kid</a></i>) also suffered from Parkinson's disease.</p>
<p>The film <i><a href="/wiki/Awakenings" title="Awakenings">Awakenings</a></i> (starring <a href="/wiki/Robin_Williams" title="Robin Williams">Robin Williams</a> and <a href="/wiki/Robert_De_Niro" title="Robert De Niro">Robert De Niro</a> and based on genuine cases reported by <a href="/wiki/Oliver_Sacks" title="Oliver Sacks">Oliver Sacks</a>) deals sensitively and largely accurately with a similar disease, <a href="/wiki/Postencephalitic_parkinsonism" title="Postencephalitic parkinsonism">postencephalitic parkinsonism</a>.</p>
<p><a href="/wiki/Michael_Gibson_(TV_presenter)" title="Michael Gibson (TV presenter)">Michael Gibson</a>, host of <i><a href="/wiki/MTV_Select" title="MTV Select">MTV Select</a></i>, was diagnosed with Parkinson's at the age of 18. Gibson lived in denial about his condition for six years. He then pitched a documentary proposal to <a href="/wiki/Channel_4" title="Channel 4">Channel 4</a> who commissioned him to make a documentary following Gibson's journey with Parkinson's. <a href="http://www.channel4.com/health/microsites/0-9/4health/body/ill_parkinsons_shookup.html" class="external text" title="http://www.channel4.com/health/microsites/0-9/4health/body/ill_parkinsons_shookup.html" rel="nofollow"><i>All shook up: Parkinson's at 25</i></a> aired on Channel 4 in 2006.</p>
<p>In addition, former Arsenal and <a href="/wiki/Liverpool_FC" title="Liverpool FC" class="mw-redirect">Liverpool FC</a> footballer <a href="/wiki/Ray_Kennedy" title="Ray Kennedy">Ray Kennedy</a>, who won every domestic English honour as well as the <a href="/wiki/European_Cup" title="European Cup" class="mw-redirect">European Cup</a> and <a href="/wiki/UEFA_Cup" title="UEFA Cup">UEFA Cup</a>, is a sufferer of the disease, having been diagnosed at 35.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Dopamine_dysregulation_syndrome" title="Dopamine dysregulation syndrome">Dopamine dysregulation syndrome</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="mw-headline">References</span></h2>
<div class="references-small" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-Jankovic2008-0">^ <a href="#cite_ref-Jankovic2008_0-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jankovic2008_0-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Jankovic2008_0-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFJankovic_J2008">Jankovic J (April 2008). "Parkinson's disease: clinical features and diagnosis". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>79</b> (4): 368–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.2007.131045" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.2007.131045" rel="nofollow">10.1136/jnnp.2007.131045</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18344392" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18344392">PMID 18344392</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Parkinson%27s+disease%3A+clinical+features+and+diagnosis&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Jankovic+J&amp;rft.au=Jankovic+J&amp;rft.date=April+2008&amp;rft.volume=79&amp;rft.issue=4&amp;rft.pages=368%E2%80%9376&amp;rft_id=info:doi/10.1136%2Fjnnp.2007.131045&amp;rft_id=info:pmid/18344392&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-nice35-1">^ <a href="#cite_ref-nice35_1-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-nice35_1-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-nice35_1-2" title=""><sup><i><b>c</b></i></sup></a> <a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence">National Institute for Health and Clinical Excellence</a>. <i><a href="http://guidance.nice.org.uk/CG35" class="external text" title="http://guidance.nice.org.uk/CG35" rel="nofollow">Clinical guideline 35: Parkinson's disease</a></i>. London, June 2006.</li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLepoutre_A.2C_Devos_D.2C_Blanchard-Dauphin_A.2C_.27.27et_al.27.272006">Lepoutre A, Devos D, Blanchard-Dauphin A, <i>et al</i> (2006). "A specific clinical pattern of camptocormia in Parkinson's disease". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>77</b> (11): 1229–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.2005.083998" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.2005.083998" rel="nofollow">10.1136/jnnp.2005.083998</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16735399" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16735399">PMID 16735399</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+specific+clinical+pattern+of+camptocormia+in+Parkinson%27s+disease&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Lepoutre+A%2C+Devos+D%2C+Blanchard-Dauphin+A%2C+%27%27et+al%27%27&amp;rft.au=Lepoutre+A%2C+Devos+D%2C+Blanchard-Dauphin+A%2C+%27%27et+al%27%27&amp;rft.date=2006&amp;rft.volume=77&amp;rft.issue=11&amp;rft.pages=1229%E2%80%9334&amp;rft_id=info:doi/10.1136%2Fjnnp.2005.083998&amp;rft_id=info:pmid/16735399&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFFox2003">Fox, Michael (2003). <i>Lucky Man: A Memoir</i>. Hyperion. p.&#160;214. <a href="/wiki/Special:BookSources/0786888741" class="internal">ISBN 0786888741</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Lucky+Man%3A+A+Memoir&amp;rft.aulast=Fox&amp;rft.aufirst=Michael&amp;rft.au=Fox%2C+Michael&amp;rft.date=2003&amp;rft.pages=p.%26nbsp%3B214&amp;rft.pub=Hyperion&amp;rft.isbn=0786888741&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-4"><b><a href="#cite_ref-4" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDeuschl_G.2C_Goddemeier_C1998">Deuschl G, Goddemeier C (1998). "<a href="http://jnnp.bmjjournals.com/cgi/content/full/64/3/320" class="external text" title="http://jnnp.bmjjournals.com/cgi/content/full/64/3/320" rel="nofollow">Spontaneous and reflex activity of facial muscles in dystonia, Parkinson's disease, and in normal subjects</a>". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>64</b> (3): 320–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.64.3.320" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.64.3.320" rel="nofollow">10.1136/jnnp.64.3.320</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9527141" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9527141">PMID 9527141</a><span class="printonly">. <a href="http://jnnp.bmjjournals.com/cgi/content/full/64/3/320" class="external free" title="http://jnnp.bmjjournals.com/cgi/content/full/64/3/320" rel="nofollow">http://jnnp.bmjjournals.com/cgi/content/full/64/3/320</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Spontaneous+and+reflex+activity+of+facial+muscles+in+dystonia%2C+Parkinson%27s+disease%2C+and+in+normal+subjects&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Deuschl+G%2C+Goddemeier+C&amp;rft.au=Deuschl+G%2C+Goddemeier+C&amp;rft.date=1998&amp;rft.volume=64&amp;rft.issue=3&amp;rft.pages=320%E2%80%934&amp;rft_id=info:doi/10.1136%2Fjnnp.64.3.320&amp;rft_id=info:pmid/9527141&amp;rft_id=http%3A%2F%2Fjnnp.bmjjournals.com%2Fcgi%2Fcontent%2Ffull%2F64%2F3%2F320&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLieberman_A2006">Lieberman A (2006). "Depression in Parkinson's disease—a review". <i>Acta Neurol Scand</i> <b>113</b> (1): 1–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1600-0404.2006.00536.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1600-0404.2006.00536.x" rel="nofollow">10.1111/j.1600-0404.2006.00536.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16367891" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16367891">PMID 16367891</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Depression+in+Parkinson%27s+disease%E2%80%94a+review&amp;rft.jtitle=Acta+Neurol+Scand&amp;rft.aulast=Lieberman+A&amp;rft.au=Lieberman+A&amp;rft.date=2006&amp;rft.volume=113&amp;rft.issue=1&amp;rft.pages=1%E2%80%938&amp;rft_id=info:doi/10.1111%2Fj.1600-0404.2006.00536.x&amp;rft_id=info:pmid/16367891&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFIshihara_L.2C_Brayne_C2006">Ishihara L, Brayne C (2006). "A systematic review of depression and mental illness preceding Parkinson's disease". <i>Acta Neurol Scand</i> <b>113</b> (4): 211–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1600-0404.2006.00579.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1600-0404.2006.00579.x" rel="nofollow">10.1111/j.1600-0404.2006.00579.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16542159" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16542159">PMID 16542159</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+systematic+review+of+depression+and+mental+illness+preceding+Parkinson%27s+disease&amp;rft.jtitle=Acta+Neurol+Scand&amp;rft.aulast=Ishihara+L%2C+Brayne+C&amp;rft.au=Ishihara+L%2C+Brayne+C&amp;rft.date=2006&amp;rft.volume=113&amp;rft.issue=4&amp;rft.pages=211%E2%80%9320&amp;rft_id=info:doi/10.1111%2Fj.1600-0404.2006.00579.x&amp;rft_id=info:pmid/16542159&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-7"><b><a href="#cite_ref-7" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPell_M1996">Pell M (1996). "On the receptive prosodic loss in Parkinson's disease". <i>Cortex</i> <b>32</b> (4): 693–704. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8954247" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8954247">PMID 8954247</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=On+the+receptive+prosodic+loss+in+Parkinson%27s+disease&amp;rft.jtitle=Cortex&amp;rft.aulast=Pell+M&amp;rft.au=Pell+M&amp;rft.date=1996&amp;rft.volume=32&amp;rft.issue=4&amp;rft.pages=693%E2%80%93704&amp;rft_id=info:pmid/8954247&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFrank_MJ2005">Frank MJ (2005). "Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism". <i>Journal of cognitive neuroscience</i> <b>17</b> (1): 51–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1162%2F0898929052880093" class="external text" title="http://dx.doi.org/10.1162%2F0898929052880093" rel="nofollow">10.1162/0898929052880093</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15701239" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15701239">PMID 15701239</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dynamic+dopamine+modulation+in+the+basal+ganglia%3A+a+neurocomputational+account+of+cognitive+deficits+in+medicated+and+nonmedicated+Parkinsonism&amp;rft.jtitle=Journal+of+cognitive+neuroscience&amp;rft.aulast=Frank+MJ&amp;rft.au=Frank+MJ&amp;rft.date=2005&amp;rft.volume=17&amp;rft.issue=1&amp;rft.pages=51%E2%80%9372&amp;rft_id=info:doi/10.1162%2F0898929052880093&amp;rft_id=info:pmid/15701239&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGupta_A.2C_Bluhm_R2004">Gupta A, Bluhm R (2004). "Seborrheic dermatitis". <i>Journal of the European Academy of Dermatology and Venereology&#160;: JEADV</i> <b>18</b> (1): 13–26; quiz 19–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1468-3083.2004.00693.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1468-3083.2004.00693.x" rel="nofollow">10.1111/j.1468-3083.2004.00693.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14678527" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14678527">PMID 14678527</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Seborrheic+dermatitis&amp;rft.jtitle=Journal+of+the+European+Academy+of+Dermatology+and+Venereology+%3A+JEADV&amp;rft.aulast=Gupta+A%2C+Bluhm+R&amp;rft.au=Gupta+A%2C+Bluhm+R&amp;rft.date=2004&amp;rft.volume=18&amp;rft.issue=1&amp;rft.pages=13%E2%80%9326%3B+quiz+19%E2%80%9320&amp;rft_id=info:doi/10.1111%2Fj.1468-3083.2004.00693.x&amp;rft_id=info:pmid/14678527&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDi_Monte_DA.2C_Lavasani_M.2C_Manning-Bog_AB2002">Di Monte DA, Lavasani M, Manning-Bog AB (2002). "Environmental factors in Parkinson's disease". <i>Neurotoxicology</i> <b>23</b> (4-5): 487–502. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0161-813X%2802%2900099-2" class="external text" title="http://dx.doi.org/10.1016%2FS0161-813X%2802%2900099-2" rel="nofollow">10.1016/S0161-813X(02)00099-2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12428721" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12428721">PMID 12428721</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Environmental+factors+in+Parkinson%27s+disease&amp;rft.jtitle=Neurotoxicology&amp;rft.aulast=Di+Monte+DA%2C+Lavasani+M%2C+Manning-Bog+AB&amp;rft.au=Di+Monte+DA%2C+Lavasani+M%2C+Manning-Bog+AB&amp;rft.date=2002&amp;rft.volume=23&amp;rft.issue=4-5&amp;rft.pages=487%E2%80%93502&amp;rft_id=info:doi/10.1016%2FS0161-813X%2802%2900099-2&amp;rft_id=info:pmid/12428721&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Jenner1998-11">^ <a href="#cite_ref-Jenner1998_11-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jenner1998_11-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFJenner_P1998">Jenner P (1998). "Oxidative mechanisms in nigral cell death in Parkinson's disease". <i>Mov. Disord.</i> <b>13 Suppl 1</b>: 24–34. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9613715" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9613715">PMID 9613715</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Oxidative+mechanisms+in+nigral+cell+death+in+Parkinson%27s+disease&amp;rft.jtitle=Mov.+Disord.&amp;rft.aulast=Jenner+P&amp;rft.au=Jenner+P&amp;rft.date=1998&amp;rft.volume=13+Suppl+1&amp;rft.pages=24%E2%80%9334&amp;rft_id=info:pmid/9613715&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-12"><b><a href="#cite_ref-12" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFChiueh_CC.2C_Andoh_T.2C_Lai_AR.2C_Lai_E.2C_Krishna_G2000">Chiueh CC, Andoh T, Lai AR, Lai E, Krishna G (2000). "Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals". <i>Neurotoxicity research</i> <b>2</b> (2-3): 293–310. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16787846" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16787846">PMID 16787846</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Neuroprotective+strategies+in+Parkinson%27s+disease%3A+protection+against+progressive+nigral+damage+induced+by+free+radicals&amp;rft.jtitle=Neurotoxicity+research&amp;rft.aulast=Chiueh+CC%2C+Andoh+T%2C+Lai+AR%2C+Lai+E%2C+Krishna+G&amp;rft.au=Chiueh+CC%2C+Andoh+T%2C+Lai+AR%2C+Lai+E%2C+Krishna+G&amp;rft.date=2000&amp;rft.volume=2&amp;rft.issue=2-3&amp;rft.pages=293%E2%80%93310&amp;rft_id=info:pmid/16787846&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCotzias_G1966">Cotzias G (1966). "Manganese, melanins and the extrapyramidal system". <i>J Neurosurg</i> <b>24</b> (1): Suppl:170–80. <a href="http://www.ncbi.nlm.nih.gov/pubmed/4955707" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/4955707">PMID 4955707</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Manganese%2C+melanins+and+the+extrapyramidal+system&amp;rft.jtitle=J+Neurosurg&amp;rft.aulast=Cotzias+G&amp;rft.au=Cotzias+G&amp;rft.date=1966&amp;rft.volume=24&amp;rft.issue=1&amp;rft.pages=Suppl%3A170%E2%80%9380&amp;rft_id=info:pmid/4955707&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBarbeau_A1984">Barbeau A (1984). "Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias)". <i>Neurotoxicology</i> <b>5</b> (1): 13–35. <a href="http://www.ncbi.nlm.nih.gov/pubmed/6538948" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/6538948">PMID 6538948</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Manganese+and+extrapyramidal+disorders+%28a+critical+review+and+tribute+to+Dr.+George+C.+Cotzias%29&amp;rft.jtitle=Neurotoxicology&amp;rft.aulast=Barbeau+A&amp;rft.au=Barbeau+A&amp;rft.date=1984&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=13%E2%80%9335&amp;rft_id=info:pmid/6538948&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAscherio_A.2C_Chen_H.2C_Weisskopf_M.2C_.27.27et_al.27.272006">Ascherio A, Chen H, Weisskopf M, <i>et al</i> (2006). "Pesticide exposure and risk for Parkinson's disease". <i>Ann Neurol</i> <b>60</b> (2): 197–203. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fana.20904" class="external text" title="http://dx.doi.org/10.1002%2Fana.20904" rel="nofollow">10.1002/ana.20904</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16802290" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16802290">PMID 16802290</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pesticide+exposure+and+risk+for+Parkinson%27s+disease&amp;rft.jtitle=Ann+Neurol&amp;rft.aulast=Ascherio+A%2C+Chen+H%2C+Weisskopf+M%2C+%27%27et+al%27%27&amp;rft.au=Ascherio+A%2C+Chen+H%2C+Weisskopf+M%2C+%27%27et+al%27%27&amp;rft.date=2006&amp;rft.volume=60&amp;rft.issue=2&amp;rft.pages=197%E2%80%93203&amp;rft_id=info:doi/10.1002%2Fana.20904&amp;rft_id=info:pmid/16802290&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-16"><b><a href="#cite_ref-16" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFChiueh_C.2C_Wu_R.2C_Mohanakumar_K.2C_Sternberger_L.2C_Krishna_G.2C_Obata_T.2C_Murphy_D1994">Chiueh C, Wu R, Mohanakumar K, Sternberger L, Krishna G, Obata T, Murphy D (1994). "<i>In vivo</i> generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia". <i>Ann N Y Acad Sci</i> <b>738</b>: 25–36. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7832434" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7832434">PMID 7832434</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%27%27In+vivo%27%27+generation+of+hydroxyl+radicals+and+MPTP-induced+dopaminergic+toxicity+in+the+basal+ganglia&amp;rft.jtitle=Ann+N+Y+Acad+Sci&amp;rft.aulast=Chiueh+C%2C+Wu+R%2C+Mohanakumar+K%2C+Sternberger+L%2C+Krishna+G%2C+Obata+T%2C+Murphy+D&amp;rft.au=Chiueh+C%2C+Wu+R%2C+Mohanakumar+K%2C+Sternberger+L%2C+Krishna+G%2C+Obata+T%2C+Murphy+D&amp;rft.date=1994&amp;rft.volume=738&amp;rft.pages=25%E2%80%9336&amp;rft_id=info:pmid/7832434&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-17"><b><a href="#cite_ref-17" title="">^</a></b> <cite style="font-style:normal" class="news" id="CITEREFOrr2005">Orr, Leslie (February 10, 2005). <a href="http://www.medicalnewstoday.com/medicalnews.php?newsid=19791" class="external text" title="http://www.medicalnewstoday.com/medicalnews.php?newsid=19791" rel="nofollow">"PCBs, fungicide open brain cells to Parkinson's assault"</a>. <a href="/wiki/Medical_News_Today" title="Medical News Today">Medical News Today</a><span class="printonly">. <a href="http://www.medicalnewstoday.com/medicalnews.php?newsid=19791" class="external free" title="http://www.medicalnewstoday.com/medicalnews.php?newsid=19791" rel="nofollow">http://www.medicalnewstoday.com/medicalnews.php?newsid=19791</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=PCBs%2C+fungicide+open+brain+cells+to+Parkinson%27s+assault&amp;rft.atitle=&amp;rft.aulast=Orr&amp;rft.aufirst=Leslie&amp;rft.au=Orr%2C+Leslie&amp;rft.date=February+10%2C+2005&amp;rft.pub=%5B%5BMedical+News+Today%5D%5D&amp;rft_id=http%3A%2F%2Fwww.medicalnewstoday.com%2Fmedicalnews.php%3Fnewsid%3D19791&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFManning-Bog_AB.2C_McCormack_AL.2C_Li_J.2C_Uversky_VN.2C_Fink_AL.2C_Di_Monte_DA2002">Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002). "<a href="http://www.jbc.org/cgi/content/full/277/3/1641" class="external text" title="http://www.jbc.org/cgi/content/full/277/3/1641" rel="nofollow">The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein</a>". <i>J. Biol. Chem.</i> <b>277</b> (3): 1641–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1074%2Fjbc.C100560200" class="external text" title="http://dx.doi.org/10.1074%2Fjbc.C100560200" rel="nofollow">10.1074/jbc.C100560200</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11707429" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11707429">PMID 11707429</a><span class="printonly">. <a href="http://www.jbc.org/cgi/content/full/277/3/1641" class="external free" title="http://www.jbc.org/cgi/content/full/277/3/1641" rel="nofollow">http://www.jbc.org/cgi/content/full/277/3/1641</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+herbicide+paraquat+causes+up-regulation+and+aggregation+of+alpha-synuclein+in+mice%3A+paraquat+and+alpha-synuclein&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.aulast=Manning-Bog+AB%2C+McCormack+AL%2C+Li+J%2C+Uversky+VN%2C+Fink+AL%2C+Di+Monte+DA&amp;rft.au=Manning-Bog+AB%2C+McCormack+AL%2C+Li+J%2C+Uversky+VN%2C+Fink+AL%2C+Di+Monte+DA&amp;rft.date=2002&amp;rft.volume=277&amp;rft.issue=3&amp;rft.pages=1641%E2%80%934&amp;rft_id=info:doi/10.1074%2Fjbc.C100560200&amp;rft_id=info:pmid/11707429&amp;rft_id=http%3A%2F%2Fwww.jbc.org%2Fcgi%2Fcontent%2Ffull%2F277%2F3%2F1641&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-19"><b><a href="#cite_ref-19" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThiruchelvam_M.2C_Richfield_EK.2C_Baggs_RB.2C_Tank_AW.2C_Cory-Slechta_DA2000">Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA (15 Dec 2000). "<a href="http://www.jneurosci.org/cgi/content/full/20/24/9207" class="external text" title="http://www.jneurosci.org/cgi/content/full/20/24/9207" rel="nofollow">The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease</a>". <i>J. Neurosci.</i> <b>20</b> (24): 9207–14. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11124998" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11124998">PMID 11124998</a><span class="printonly">. <a href="http://www.jneurosci.org/cgi/content/full/20/24/9207" class="external free" title="http://www.jneurosci.org/cgi/content/full/20/24/9207" rel="nofollow">http://www.jneurosci.org/cgi/content/full/20/24/9207</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+nigrostriatal+dopaminergic+system+as+a+preferential+target+of+repeated+exposures+to+combined+paraquat+and+maneb%3A+implications+for+Parkinson%27s+disease&amp;rft.jtitle=J.+Neurosci.&amp;rft.aulast=Thiruchelvam+M%2C+Richfield+EK%2C+Baggs+RB%2C+Tank+AW%2C+Cory-Slechta+DA&amp;rft.au=Thiruchelvam+M%2C+Richfield+EK%2C+Baggs+RB%2C+Tank+AW%2C+Cory-Slechta+DA&amp;rft.date=15+Dec+2000&amp;rft.volume=20&amp;rft.issue=24&amp;rft.pages=9207%E2%80%9314&amp;rft_id=info:pmid/11124998&amp;rft_id=http%3A%2F%2Fwww.jneurosci.org%2Fcgi%2Fcontent%2Ffull%2F20%2F24%2F9207&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBetarbet_R.2C_Sherer_TB.2C_MacKenzie_G.2C_Garcia-Osuna_M.2C_Panov_AV.2C_Greenamyre_JT2000">Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000). "Chronic systemic pesticide exposure reproduces features of Parkinson's disease". <i>Nat. Neurosci.</i> <b>3</b> (12): 1301–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2F81834" class="external text" title="http://dx.doi.org/10.1038%2F81834" rel="nofollow">10.1038/81834</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11100151" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11100151">PMID 11100151</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Chronic+systemic+pesticide+exposure+reproduces+features+of+Parkinson%27s+disease&amp;rft.jtitle=Nat.+Neurosci.&amp;rft.aulast=Betarbet+R%2C+Sherer+TB%2C+MacKenzie+G%2C+Garcia-Osuna+M%2C+Panov+AV%2C+Greenamyre+JT&amp;rft.au=Betarbet+R%2C+Sherer+TB%2C+MacKenzie+G%2C+Garcia-Osuna+M%2C+Panov+AV%2C+Greenamyre+JT&amp;rft.date=2000&amp;rft.volume=3&amp;rft.issue=12&amp;rft.pages=1301%E2%80%936&amp;rft_id=info:doi/10.1038%2F81834&amp;rft_id=info:pmid/11100151&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-21"><b><a href="#cite_ref-21" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKitazawa_M.2C_Anantharam_V.2C_Kanthasamy_AG2001">Kitazawa M, Anantharam V, Kanthasamy AG (2001). "<a href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6T38-44HSN76-P&amp;_coverDate=12%2F01%2F2001&amp;_alid=373422978&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_qd=1&amp;_cdi=4940&amp;_sort=d&amp;view=c&amp;_acct=C000050221&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=5a104ac89bd7948e14863371142a639a" class="external text" title="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6T38-44HSN76-P&amp;_coverDate=12%2F01%2F2001&amp;_alid=373422978&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_qd=1&amp;_cdi=4940&amp;_sort=d&amp;view=c&amp;_acct=C000050221&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=5a104ac89bd7948e14863371142a639a" rel="nofollow">Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells</a>". <i>Free Radic. Biol. Med.</i> <b>31</b> (11): 1473–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0891-5849%2801%2900726-2" class="external text" title="http://dx.doi.org/10.1016%2FS0891-5849%2801%2900726-2" rel="nofollow">10.1016/S0891-5849(01)00726-2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11728820" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11728820">PMID 11728820</a><span class="printonly">. <a href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6T38-44HSN76-P&amp;_coverDate=12%2F01%2F2001&amp;_alid=373422978&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_qd=1&amp;_cdi=4940&amp;_sort=d&amp;view=c&amp;_acct=C000050221&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=5a104ac89bd7948e14863371142a639a" class="external free" title="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6T38-44HSN76-P&amp;_coverDate=12%2F01%2F2001&amp;_alid=373422978&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_qd=1&amp;_cdi=4940&amp;_sort=d&amp;view=c&amp;_acct=C000050221&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=5a104ac89bd7948e14863371142a639a" rel="nofollow">http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6T38-44HSN76-P&amp;_coverDate=12%2F01%2F2001&amp;_alid=373422978&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_qd=1&amp;_cdi=4940&amp;_sort=d&amp;view=c&amp;_acct=C000050221&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=5a104ac89bd7948e14863371142a639a</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dieldrin-induced+oxidative+stress+and+neurochemical+changes+contribute+to+apoptopic+cell+death+in+dopaminergic+cells&amp;rft.jtitle=Free+Radic.+Biol.+Med.&amp;rft.aulast=Kitazawa+M%2C+Anantharam+V%2C+Kanthasamy+AG&amp;rft.au=Kitazawa+M%2C+Anantharam+V%2C+Kanthasamy+AG&amp;rft.date=2001&amp;rft.volume=31&amp;rft.issue=11&amp;rft.pages=1473%E2%80%9385&amp;rft_id=info:doi/10.1016%2FS0891-5849%2801%2900726-2&amp;rft_id=info:pmid/11728820&amp;rft_id=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%3F_ob%3DArticleURL%26_udi%3DB6T38-44HSN76-P%26_coverDate%3D12%252F01%252F2001%26_alid%3D373422978%26_rdoc%3D1%26_fmt%3D%26_orig%3Dsearch%26_qd%3D1%26_cdi%3D4940%26_sort%3Dd%26view%3Dc%26_acct%3DC000050221%26_version%3D1%26_urlVersion%3D0%26_userid%3D10%26md5%3D5a104ac89bd7948e14863371142a639a&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-22"><b><a href="#cite_ref-22" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCorrigan_FM.2C_Wienburg_CL.2C_Shore_RF.2C_Daniel_SE.2C_Mann_D2000">Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D (2000). "<a href="http://journalsonline.tandf.co.uk/openurl.asp?genre=article&amp;eissn=1087-2620&amp;volume=59&amp;issue=4&amp;spage=229" class="external text" title="http://journalsonline.tandf.co.uk/openurl.asp?genre=article&amp;eissn=1087-2620&amp;volume=59&amp;issue=4&amp;spage=229" rel="nofollow">Organochlorine insecticides in substantia nigra in Parkinson's disease</a>". <i>J. Toxicol. Environ. Health Part A</i> <b>59</b> (4): 229–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1080%2F009841000156907" class="external text" title="http://dx.doi.org/10.1080%2F009841000156907" rel="nofollow">10.1080/009841000156907</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10706031" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10706031">PMID 10706031</a><span class="printonly">. <a href="http://journalsonline.tandf.co.uk/openurl.asp?genre=article&amp;eissn=1087-2620&amp;volume=59&amp;issue=4&amp;spage=229" class="external free" title="http://journalsonline.tandf.co.uk/openurl.asp?genre=article&amp;eissn=1087-2620&amp;volume=59&amp;issue=4&amp;spage=229" rel="nofollow">http://journalsonline.tandf.co.uk/openurl.asp?genre=article&amp;eissn=1087-2620&amp;volume=59&amp;issue=4&amp;spage=229</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Organochlorine+insecticides+in+substantia+nigra+in+Parkinson%27s+disease&amp;rft.jtitle=J.+Toxicol.+Environ.+Health+Part+A&amp;rft.aulast=Corrigan+FM%2C+Wienburg+CL%2C+Shore+RF%2C+Daniel+SE%2C+Mann+D&amp;rft.au=Corrigan+FM%2C+Wienburg+CL%2C+Shore+RF%2C+Daniel+SE%2C+Mann+D&amp;rft.date=2000&amp;rft.volume=59&amp;rft.issue=4&amp;rft.pages=229%E2%80%9334&amp;rft_id=info:doi/10.1080%2F009841000156907&amp;rft_id=info:pmid/10706031&amp;rft_id=http%3A%2F%2Fjournalsonline.tandf.co.uk%2Fopenurl.asp%3Fgenre%3Darticle%26eissn%3D1087-2620%26volume%3D59%26issue%3D4%26spage%3D229&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Bower-23">^ <a href="#cite_ref-Bower_23-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bower_23-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBower_JH.2C_Maraganore_DM.2C_Peterson_BJ.2C_McDonnell_SK.2C_Ahlskog_JE.2C_Rocca_WA2003">Bower JH, Maraganore DM, Peterson BJ, McDonnell SK, Ahlskog JE, Rocca WA (27 May 2003). "<a href="http://www.neurology.org/cgi/content/abstract/60/10/1610" class="external text" title="http://www.neurology.org/cgi/content/abstract/60/10/1610" rel="nofollow">Head trauma preceding PD: a case-control study</a>" (abstract page). <i>Neurology</i> <b>60</b> (10): 1610–5. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12771250" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12771250">PMID 12771250</a><span class="printonly">. <a href="http://www.neurology.org/cgi/content/abstract/60/10/1610" class="external free" title="http://www.neurology.org/cgi/content/abstract/60/10/1610" rel="nofollow">http://www.neurology.org/cgi/content/abstract/60/10/1610</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Head+trauma+preceding+PD%3A+a+case-control+study&amp;rft.jtitle=Neurology&amp;rft.aulast=Bower+JH%2C+Maraganore+DM%2C+Peterson+BJ%2C+McDonnell+SK%2C+Ahlskog+JE%2C+Rocca+WA&amp;rft.au=Bower+JH%2C+Maraganore+DM%2C+Peterson+BJ%2C+McDonnell+SK%2C+Ahlskog+JE%2C+Rocca+WA&amp;rft.date=27+May+2003&amp;rft.volume=60&amp;rft.issue=10&amp;rft.pages=1610%E2%80%935&amp;rft_id=info:pmid/12771250&amp;rft_id=http%3A%2F%2Fwww.neurology.org%2Fcgi%2Fcontent%2Fabstract%2F60%2F10%2F1610&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStern_M.2C_Dulaney_E.2C_Gruber_SB.2C_.27.27et_al.27.271991">Stern M, Dulaney E, Gruber SB, <i>et al</i> (1991). "The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients". <i>Arch. Neurol.</i> <b>48</b> (9): 903–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1953412" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1953412">PMID 1953412</a> url=<a href="http://archneur.ama-assn.org/cgi/content/abstract/48/9/903" class="external free" title="http://archneur.ama-assn.org/cgi/content/abstract/48/9/903" rel="nofollow">http://archneur.ama-assn.org/cgi/content/abstract/48/9/903</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+epidemiology+of+Parkinson%27s+disease.+A+case-control+study+of+young-onset+and+old-onset+patients&amp;rft.jtitle=Arch.+Neurol.&amp;rft.aulast=Stern+M%2C+Dulaney+E%2C+Gruber+SB%2C+%27%27et+al%27%27&amp;rft.au=Stern+M%2C+Dulaney+E%2C+Gruber+SB%2C+%27%27et+al%27%27&amp;rft.date=1991&amp;rft.volume=48&amp;rft.issue=9&amp;rft.pages=903%E2%80%937&amp;rft_id=info:pmid/1953412++url%3Dhttp%3A%2F%2Farchneur.ama-assn.org%2Fcgi%2Fcontent%2Fabstract%2F48%2F9%2F903&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Uryu2003-25"><b><a href="#cite_ref-Uryu2003_25-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFUryu_K.2C_Giasson_BI.2C_Longhi_L.2C_.27.27et_al.27.272003">Uryu K, Giasson BI, Longhi L, <i>et al</i> (2003). "Age-dependent synuclein pathology following traumatic brain injury in mice". <i>Exp. Neurol.</i> <b>184</b> (1): 214–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0014-4886%2803%2900245-0" class="external text" title="http://dx.doi.org/10.1016%2FS0014-4886%2803%2900245-0" rel="nofollow">10.1016/S0014-4886(03)00245-0</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14637093" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14637093">PMID 14637093</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Age-dependent+synuclein+pathology+following+traumatic+brain+injury+in+mice&amp;rft.jtitle=Exp.+Neurol.&amp;rft.aulast=Uryu+K%2C+Giasson+BI%2C+Longhi+L%2C+%27%27et+al%27%27&amp;rft.au=Uryu+K%2C+Giasson+BI%2C+Longhi+L%2C+%27%27et+al%27%27&amp;rft.date=2003&amp;rft.volume=184&amp;rft.issue=1&amp;rft.pages=214%E2%80%9324&amp;rft_id=info:doi/10.1016%2FS0014-4886%2803%2900245-0&amp;rft_id=info:pmid/14637093&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-26"><b><a href="#cite_ref-26" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGoldman_SM.2C_Tanner_CM.2C_Oakes_D.2C_Bhudhikanok_GS.2C_Gupta_A.2C_Langston_JW2006">Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW (2006). "Head injury and Parkinson's disease risk in twins". <i>Ann. Neurol.</i> <b>60</b> (1): 65–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fana.20882" class="external text" title="http://dx.doi.org/10.1002%2Fana.20882" rel="nofollow">10.1002/ana.20882</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16718702" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16718702">PMID 16718702</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Head+injury+and+Parkinson%27s+disease+risk+in+twins&amp;rft.jtitle=Ann.+Neurol.&amp;rft.aulast=Goldman+SM%2C+Tanner+CM%2C+Oakes+D%2C+Bhudhikanok+GS%2C+Gupta+A%2C+Langston+JW&amp;rft.au=Goldman+SM%2C+Tanner+CM%2C+Oakes+D%2C+Bhudhikanok+GS%2C+Gupta+A%2C+Langston+JW&amp;rft.date=2006&amp;rft.volume=60&amp;rft.issue=1&amp;rft.pages=65%E2%80%9372&amp;rft_id=info:doi/10.1002%2Fana.20882&amp;rft_id=info:pmid/16718702&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-27"><b><a href="#cite_ref-27" title="">^</a></b> "Parkinson's Disease Mechanism Discovered," <a href="http://www.hhmi.org/news/lindquist20060622.html" class="external text" title="http://www.hhmi.org/news/lindquist20060622.html" rel="nofollow">HHMI Research News</a> June 22, 2006.</li>
<li id="cite_note-28"><b><a href="#cite_ref-28" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKaur_D.2C_Andersen_J2002">Kaur D, Andersen J (2002). "<a href="http://www.blackwell-synergy.com/doi/pdf/10.1046/j.1474-9728.2002.00001.x" class="external text" title="http://www.blackwell-synergy.com/doi/pdf/10.1046/j.1474-9728.2002.00001.x" rel="nofollow">Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?</a>" (PDF). <i>Aging Cell</i> <b>1</b> (1): 17–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1474-9728.2002.00001.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1474-9728.2002.00001.x" rel="nofollow">10.1046/j.1474-9728.2002.00001.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12882349" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12882349">PMID 12882349</a><span class="printonly">. <a href="http://www.blackwell-synergy.com/doi/pdf/10.1046/j.1474-9728.2002.00001.x" class="external free" title="http://www.blackwell-synergy.com/doi/pdf/10.1046/j.1474-9728.2002.00001.x" rel="nofollow">http://www.blackwell-synergy.com/doi/pdf/10.1046/j.1474-9728.2002.00001.x</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Ironing+out+Parkinson%27s+disease%3A+is+therapeutic+treatment+with+iron+chelators+a+real+possibility%3F&amp;rft.jtitle=Aging+Cell&amp;rft.aulast=Kaur+D%2C+Andersen+J&amp;rft.au=Kaur+D%2C+Andersen+J&amp;rft.date=2002&amp;rft.volume=1&amp;rft.issue=1&amp;rft.pages=17%E2%80%9321&amp;rft_id=info:doi/10.1046%2Fj.1474-9728.2002.00001.x&amp;rft_id=info:pmid/12882349&amp;rft_id=http%3A%2F%2Fwww.blackwell-synergy.com%2Fdoi%2Fpdf%2F10.1046%2Fj.1474-9728.2002.00001.x&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-29"><b><a href="#cite_ref-29" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMasliah_E.2C_Rockenstein_E.2C_Veinbergs_I.2C_.27.27et_al.27.272000">Masliah E, Rockenstein E, Veinbergs I, <i>et al</i> (2000). "Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders". <i>Science</i> <b>287</b> (5456): 1265–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1126%2Fscience.287.5456.1265" class="external text" title="http://dx.doi.org/10.1126%2Fscience.287.5456.1265" rel="nofollow">10.1126/science.287.5456.1265</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10678833" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10678833">PMID 10678833</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dopaminergic+loss+and+inclusion+body+formation+in+alpha-synuclein+mice%3A+implications+for+neurodegenerative+disorders&amp;rft.jtitle=Science&amp;rft.aulast=Masliah+E%2C+Rockenstein+E%2C+Veinbergs+I%2C+%27%27et+al%27%27&amp;rft.au=Masliah+E%2C+Rockenstein+E%2C+Veinbergs+I%2C+%27%27et+al%27%27&amp;rft.date=2000&amp;rft.volume=287&amp;rft.issue=5456&amp;rft.pages=1265%E2%80%939&amp;rft_id=info:doi/10.1126%2Fscience.287.5456.1265&amp;rft_id=info:pmid/10678833&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-30"><b><a href="#cite_ref-30" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGelb_D.2C_Oliver_E.2C_Gilman_S1999">Gelb D, Oliver E, Gilman S (1999). "Diagnostic criteria for Parkinson disease". <i>Arch Neurol</i> <b>56</b> (1): 33–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchneur.56.1.33" class="external text" title="http://dx.doi.org/10.1001%2Farchneur.56.1.33" rel="nofollow">10.1001/archneur.56.1.33</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9923759" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9923759">PMID 9923759</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Diagnostic+criteria+for+Parkinson+disease&amp;rft.jtitle=Arch+Neurol&amp;rft.aulast=Gelb+D%2C+Oliver+E%2C+Gilman+S&amp;rft.au=Gelb+D%2C+Oliver+E%2C+Gilman+S&amp;rft.date=1999&amp;rft.volume=56&amp;rft.issue=1&amp;rft.pages=33%E2%80%939&amp;rft_id=info:doi/10.1001%2Farchneur.56.1.33&amp;rft_id=info:pmid/9923759&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-TNcilia-31"><b><a href="#cite_ref-TNcilia_31-0" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFR._Cilia_.27.27et_al..27.272006">R. Cilia <i>et al.</i> (2006). <a href="http://www.touchneurology.com/articles.cfm?article_id=5728&amp;level=2" class="external text" title="http://www.touchneurology.com/articles.cfm?article_id=5728&amp;level=2" rel="nofollow">"Long-term Efficacy of Entacapone in Patients with Parkinson's Disease and Motor Fluctuations - A Six-Year Clinical Follow-Up Study"</a><span class="printonly">. <a href="http://www.touchneurology.com/articles.cfm?article_id=5728&amp;level=2" class="external free" title="http://www.touchneurology.com/articles.cfm?article_id=5728&amp;level=2" rel="nofollow">http://www.touchneurology.com/articles.cfm?article_id=5728&amp;level=2</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Long-term+Efficacy+of+Entacapone+in+Patients+with+Parkinson%27s+Disease+and+Motor+Fluctuations+-+A+Six-Year+Clinical+Follow-Up+Study&amp;rft.atitle=&amp;rft.aulast=R.+Cilia+%27%27et+al.%27%27&amp;rft.au=R.+Cilia+%27%27et+al.%27%27&amp;rft.date=2006&amp;rft_id=http%3A%2F%2Fwww.touchneurology.com%2Farticles.cfm%3Farticle_id%3D5728%26level%3D2&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-32"><b><a href="#cite_ref-32" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThorogood_M.2C_Armstrong_B.2C_Nichols_T.2C_Hollowell_J1998">Thorogood M, Armstrong B, Nichols T, Hollowell J (1998). "Mortality in people taking selegiline: observational study". <i>BMJ</i> <b>317</b> (7153): 252–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9677215" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9677215">PMID 9677215</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mortality+in+people+taking+selegiline%3A+observational+study&amp;rft.jtitle=BMJ&amp;rft.aulast=Thorogood+M%2C+Armstrong+B%2C+Nichols+T%2C+Hollowell+J&amp;rft.au=Thorogood+M%2C+Armstrong+B%2C+Nichols+T%2C+Hollowell+J&amp;rft.date=1998&amp;rft.volume=317&amp;rft.issue=7153&amp;rft.pages=252%E2%80%934&amp;rft_id=info:pmid/9677215&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-33"><b><a href="#cite_ref-33" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMarras_C.2C_McDermott_M.2C_Rochon_P.2C_Tanner_C.2C_Naglie_G.2C_Rudolph_A.2C_Lang_A2005">Marras C, McDermott M, Rochon P, Tanner C, Naglie G, Rudolph A, Lang A (2005). "Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort". <i>Neurology</i> <b>64</b> (1): 87–93. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15642909" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15642909">PMID 15642909</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Survival+in+Parkinson+disease%3A+thirteen-year+follow-up+of+the+DATATOP+cohort&amp;rft.jtitle=Neurology&amp;rft.aulast=Marras+C%2C+McDermott+M%2C+Rochon+P%2C+Tanner+C%2C+Naglie+G%2C+Rudolph+A%2C+Lang+A&amp;rft.au=Marras+C%2C+McDermott+M%2C+Rochon+P%2C+Tanner+C%2C+Naglie+G%2C+Rudolph+A%2C+Lang+A&amp;rft.date=2005&amp;rft.volume=64&amp;rft.issue=1&amp;rft.pages=87%E2%80%9393&amp;rft_id=info:pmid/15642909&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-34"><b><a href="#cite_ref-34" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGuridi_J.2C_Obeso_JA2001">Guridi J, Obeso JA (2001). "<a href="http://brain.oxfordjournals.org/cgi/content/full/124/1/5" class="external text" title="http://brain.oxfordjournals.org/cgi/content/full/124/1/5" rel="nofollow">The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma</a>". <i>Brain</i> <b>124</b> (Pt 1): 5–19. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Fbrain%2F124.1.5" class="external text" title="http://dx.doi.org/10.1093%2Fbrain%2F124.1.5" rel="nofollow">10.1093/brain/124.1.5</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11133783" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11133783">PMID 11133783</a><span class="printonly">. <a href="http://brain.oxfordjournals.org/cgi/content/full/124/1/5" class="external free" title="http://brain.oxfordjournals.org/cgi/content/full/124/1/5" rel="nofollow">http://brain.oxfordjournals.org/cgi/content/full/124/1/5</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+subthalamic+nucleus%2C+hemiballismus+and+Parkinson%27s+disease%3A+reappraisal+of+a+neurosurgical+dogma&amp;rft.jtitle=Brain&amp;rft.aulast=Guridi+J%2C+Obeso+JA&amp;rft.au=Guridi+J%2C+Obeso+JA&amp;rft.date=2001&amp;rft.volume=124&amp;rft.issue=Pt+1&amp;rft.pages=5%E2%80%9319&amp;rft_id=info:doi/10.1093%2Fbrain%2F124.1.5&amp;rft_id=info:pmid/11133783&amp;rft_id=http%3A%2F%2Fbrain.oxfordjournals.org%2Fcgi%2Fcontent%2Ffull%2F124%2F1%2F5&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-35"><b><a href="#cite_ref-35" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFukuda_M.2C_Kameyama_S.2C_Yoshino_M.2C_Tanaka_R.2C_Narabayashi_H2000">Fukuda M, Kameyama S, Yoshino M, Tanaka R, Narabayashi H (2000). "Neuropsychological outcome following pallidotomy and thalamotomy for Parkinson's disease". <i>Stereotactic and functional neurosurgery</i> <b>74</b> (1): 11–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1159%2F000056458" class="external text" title="http://dx.doi.org/10.1159%2F000056458" rel="nofollow">10.1159/000056458</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11124660" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11124660">PMID 11124660</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Neuropsychological+outcome+following+pallidotomy+and+thalamotomy+for+Parkinson%27s+disease&amp;rft.jtitle=Stereotactic+and+functional+neurosurgery&amp;rft.aulast=Fukuda+M%2C+Kameyama+S%2C+Yoshino+M%2C+Tanaka+R%2C+Narabayashi+H&amp;rft.au=Fukuda+M%2C+Kameyama+S%2C+Yoshino+M%2C+Tanaka+R%2C+Narabayashi+H&amp;rft.date=2000&amp;rft.volume=74&amp;rft.issue=1&amp;rft.pages=11%E2%80%9320&amp;rft_id=info:doi/10.1159%2F000056458&amp;rft_id=info:pmid/11124660&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11687029-36"><b><a href="#cite_ref-pmid11687029_36-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDeane_KH.2C_Jones_D.2C_Playford_ED.2C_Ben-Shlomo_Y.2C_Clarke_CE2001">Deane KH, Jones D, Playford ED, Ben-Shlomo Y, Clarke CE (2001). "Physiotherapy for patients with Parkinson's Disease: a comparison of techniques". <i>Cochrane Database Syst Rev</i> (3): CD002817. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD002817" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD002817" rel="nofollow">10.1002/14651858.CD002817</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11687029" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11687029">PMID 11687029</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Physiotherapy+for+patients+with+Parkinson%27s+Disease%3A+a+comparison+of+techniques&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.aulast=Deane+KH%2C+Jones+D%2C+Playford+ED%2C+Ben-Shlomo+Y%2C+Clarke+CE&amp;rft.au=Deane+KH%2C+Jones+D%2C+Playford+ED%2C+Ben-Shlomo+Y%2C+Clarke+CE&amp;rft.date=2001&amp;rft.issue=3&amp;rft.pages=CD002817&amp;rft_id=info:doi/10.1002%2F14651858.CD002817&amp;rft_id=info:pmid/11687029&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid11406045-37"><b><a href="#cite_ref-pmid11406045_37-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDeane_KH.2C_Whurr_R.2C_Playford_ED.2C_Ben-Shlomo_Y.2C_Clarke_CE2001">Deane KH, Whurr R, Playford ED, Ben-Shlomo Y, Clarke CE (2001). "A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease". <i>Cochrane Database Syst Rev</i> (2): CD002814. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD002814" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD002814" rel="nofollow">10.1002/14651858.CD002814</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11406045" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11406045">PMID 11406045</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+comparison+of+speech+and+language+therapy+techniques+for+dysarthria+in+Parkinson%27s+disease&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.aulast=Deane+KH%2C+Whurr+R%2C+Playford+ED%2C+Ben-Shlomo+Y%2C+Clarke+CE&amp;rft.au=Deane+KH%2C+Whurr+R%2C+Playford+ED%2C+Ben-Shlomo+Y%2C+Clarke+CE&amp;rft.date=2001&amp;rft.issue=2&amp;rft.pages=CD002814&amp;rft_id=info:doi/10.1002%2F14651858.CD002814&amp;rft_id=info:pmid/11406045&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18181210-38">^ <a href="#cite_ref-pmid18181210_38-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18181210_38-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFGoodwin_VA.2C_Richards_SH.2C_Taylor_RS.2C_Taylor_AH.2C_Campbell_JL2008">Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL (April 2008). "The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis". <i>Mov. Disord.</i> <b>23</b> (5): 631–40. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fmds.21922" class="external text" title="http://dx.doi.org/10.1002%2Fmds.21922" rel="nofollow">10.1002/mds.21922</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18181210" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18181210">PMID 18181210</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+effectiveness+of+exercise+interventions+for+people+with+Parkinson%27s+disease%3A+a+systematic+review+and+meta-analysis&amp;rft.jtitle=Mov.+Disord.&amp;rft.aulast=Goodwin+VA%2C+Richards+SH%2C+Taylor+RS%2C+Taylor+AH%2C+Campbell+JL&amp;rft.au=Goodwin+VA%2C+Richards+SH%2C+Taylor+RS%2C+Taylor+AH%2C+Campbell+JL&amp;rft.date=April+2008&amp;rft.volume=23&amp;rft.issue=5&amp;rft.pages=631%E2%80%9340&amp;rft_id=info:doi/10.1002%2Fmds.21922&amp;rft_id=info:pmid/18181210&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12132992-39">^ <a href="#cite_ref-pmid12132992_39-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12132992_39-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFSchulz_GM2002">Schulz GM (July 2002). "<a href="http://www.bentham-direct.org/pages/content.php?CMC/2002/00000009/00000014/0003C.SGM" class="external text" title="http://www.bentham-direct.org/pages/content.php?CMC/2002/00000009/00000014/0003C.SGM" rel="nofollow">The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson s disease: a review of the literature</a>". <i>Curr. Med. Chem.</i> <b>9</b> (14): 1359–66. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12132992" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12132992">PMID 12132992</a><span class="printonly">. <a href="http://www.bentham-direct.org/pages/content.php?CMC/2002/00000009/00000014/0003C.SGM" class="external free" title="http://www.bentham-direct.org/pages/content.php?CMC/2002/00000009/00000014/0003C.SGM" rel="nofollow">http://www.bentham-direct.org/pages/content.php?CMC/2002/00000009/00000014/0003C.SGM</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+effects+of+speech+therapy+and+pharmacological+treatments+on+voice+and+speech+in+Parkinson+s+disease%3A+a+review+of+the+literature&amp;rft.jtitle=Curr.+Med.+Chem.&amp;rft.aulast=Schulz+GM&amp;rft.au=Schulz+GM&amp;rft.date=July+2002&amp;rft.volume=9&amp;rft.issue=14&amp;rft.pages=1359%E2%80%9366&amp;rft_id=info:pmid/12132992&amp;rft_id=http%3A%2F%2Fwww.bentham-direct.org%2Fpages%2Fcontent.php%3FCMC%2F2002%2F00000009%2F00000014%2F0003C.SGM&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17117354-40"><b><a href="#cite_ref-pmid17117354_40-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFox_CM.2C_Ramig_LO.2C_Ciucci_MR.2C_Sapir_S.2C_McFarland_DH.2C_Farley_BG2006">Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG (November 2006). "The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders". <i>Semin Speech Lang</i> <b>27</b> (4): 283–99. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1055%2Fs-2006-955118" class="external text" title="http://dx.doi.org/10.1055%2Fs-2006-955118" rel="nofollow">10.1055/s-2006-955118</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17117354" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17117354">PMID 17117354</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+science+and+practice+of+LSVT%2FLOUD%3A+neural+plasticity-principled+approach+to+treating+individuals+with+Parkinson+disease+and+other+neurological+disorders&amp;rft.jtitle=Semin+Speech+Lang&amp;rft.aulast=Fox+CM%2C+Ramig+LO%2C+Ciucci+MR%2C+Sapir+S%2C+McFarland+DH%2C+Farley+BG&amp;rft.au=Fox+CM%2C+Ramig+LO%2C+Ciucci+MR%2C+Sapir+S%2C+McFarland+DH%2C+Farley+BG&amp;rft.date=November+2006&amp;rft.volume=27&amp;rft.issue=4&amp;rft.pages=283%E2%80%9399&amp;rft_id=info:doi/10.1055%2Fs-2006-955118&amp;rft_id=info:pmid/17117354&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://cancercenter.mayo.edu/mayo/research/parkinsons/" class="external text" title="http://cancercenter.mayo.edu/mayo/research/parkinsons/" rel="nofollow">"Parkinson's Disease"</a>. Mayo Clinic: College of Medicine<span class="printonly">. <a href="http://cancercenter.mayo.edu/mayo/research/parkinsons/" class="external free" title="http://cancercenter.mayo.edu/mayo/research/parkinsons/" rel="nofollow">http://cancercenter.mayo.edu/mayo/research/parkinsons/</a></span><span class="reference-accessdate">. Retrieved on 2006-11-04</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Parkinson%27s+Disease&amp;rft.atitle=&amp;rft.pub=Mayo+Clinic%3A+College+of+Medicine&amp;rft_id=http%3A%2F%2Fcancercenter.mayo.edu%2Fmayo%2Fresearch%2Fparkinsons%2F&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-42"><b><a href="#cite_ref-42" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGoetz_CG.2C_Stebbins_GT1995">Goetz CG, Stebbins GT (1995). "Mortality and hallucinations in nursing home patients with advanced Parkinson's disease". <i>Neurology</i> <b>45</b> (4): 669–71. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7723953" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7723953">PMID 7723953</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mortality+and+hallucinations+in+nursing+home+patients+with+advanced+Parkinson%27s+disease&amp;rft.jtitle=Neurology&amp;rft.aulast=Goetz+CG%2C+Stebbins+GT&amp;rft.au=Goetz+CG%2C+Stebbins+GT&amp;rft.date=1995&amp;rft.volume=45&amp;rft.issue=4&amp;rft.pages=669%E2%80%9371&amp;rft_id=info:pmid/7723953&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-holisticonline.com-43">^ <a href="#cite_ref-holisticonline.com_43-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-holisticonline.com_43-1" title=""><sup><i><b>b</b></i></sup></a> <a href="http://holisticonline.com/Remedies/Parkinson/pd_who-gets.htm" class="external free" title="http://holisticonline.com/Remedies/Parkinson/pd_who-gets.htm" rel="nofollow">http://holisticonline.com/Remedies/Parkinson/pd_who-gets.htm</a></li>
<li id="cite_note-44"><b><a href="#cite_ref-44" title="">^</a></b> <a href="http://archneur.ama-assn.org/cgi/content/abstract/45/12/1321" class="external free" title="http://archneur.ama-assn.org/cgi/content/abstract/45/12/1321" rel="nofollow">http://archneur.ama-assn.org/cgi/content/abstract/45/12/1321</a></li>
<li id="cite_note-45"><b><a href="#cite_ref-45" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFManyam_BV.2C_S.C3.A1nchez-Ramos_JR1999">Manyam BV, Sánchez-Ramos JR (1999). "Traditional and complementary therapies in Parkinson's disease". <i>Advances in neurology</i> <b>80</b>: 565–74. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10410773" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10410773">PMID 10410773</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Traditional+and+complementary+therapies+in+Parkinson%27s+disease&amp;rft.jtitle=Advances+in+neurology&amp;rft.aulast=Manyam+BV%2C+S%C3%A1nchez-Ramos+JR&amp;rft.au=Manyam+BV%2C+S%C3%A1nchez-Ramos+JR&amp;rft.date=1999&amp;rft.volume=80&amp;rft.pages=565%E2%80%9374&amp;rft_id=info:pmid/10410773&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-46"><b><a href="#cite_ref-46" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFParkinson_J2002">Parkinson J (2002). "<a href="http://neuro.psychiatryonline.org/cgi/content/full/14/2/223" class="external text" title="http://neuro.psychiatryonline.org/cgi/content/full/14/2/223" rel="nofollow">An essay on the shaking palsy. 1817</a>" (Reproduced). <i>J Neuropsychiatry Clin Neurosci</i> <b>14</b> (2): 223–36; discussion 222. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1176%2Fappi.neuropsych.14.2.223" class="external text" title="http://dx.doi.org/10.1176%2Fappi.neuropsych.14.2.223" rel="nofollow">10.1176/appi.neuropsych.14.2.223</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11983801" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11983801">PMID 11983801</a><span class="printonly">. <a href="http://neuro.psychiatryonline.org/cgi/content/full/14/2/223" class="external free" title="http://neuro.psychiatryonline.org/cgi/content/full/14/2/223" rel="nofollow">http://neuro.psychiatryonline.org/cgi/content/full/14/2/223</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=An+essay+on+the+shaking+palsy.+1817&amp;rft.jtitle=J+Neuropsychiatry+Clin+Neurosci&amp;rft.aulast=Parkinson+J&amp;rft.au=Parkinson+J&amp;rft.date=2002&amp;rft.volume=14&amp;rft.issue=2&amp;rft.pages=223%E2%80%9336%3B+discussion+222&amp;rft_id=info:doi/10.1176%2Fappi.neuropsych.14.2.223&amp;rft_id=info:pmid/11983801&amp;rft_id=http%3A%2F%2Fneuro.psychiatryonline.org%2Fcgi%2Fcontent%2Ffull%2F14%2F2%2F223&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-47"><b><a href="#cite_ref-47" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHornykiewicz_O2002">Hornykiewicz O (2002). "L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent". <i>Amino Acids</i> <b>23</b> (1-3): 65–70. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00726-001-0111-9" class="external text" title="http://dx.doi.org/10.1007%2Fs00726-001-0111-9" rel="nofollow">10.1007/s00726-001-0111-9</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12373520" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12373520">PMID 12373520</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=L-DOPA%3A+from+a+biologically+inactive+amino+acid+to+a+successful+therapeutic+agent&amp;rft.jtitle=Amino+Acids&amp;rft.aulast=Hornykiewicz+O&amp;rft.au=Hornykiewicz+O&amp;rft.date=2002&amp;rft.volume=23&amp;rft.issue=1-3&amp;rft.pages=65%E2%80%9370&amp;rft_id=info:doi/10.1007%2Fs00726-001-0111-9&amp;rft_id=info:pmid/12373520&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-48"><b><a href="#cite_ref-48" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCotzias_G1968">Cotzias G (1968). "L-Dopa for Parkinsonism". <i>N Engl J Med</i> <b>278</b> (11): 630. <a href="http://www.ncbi.nlm.nih.gov/pubmed/5637779" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/5637779">PMID 5637779</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=L-Dopa+for+Parkinsonism&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Cotzias+G&amp;rft.au=Cotzias+G&amp;rft.date=1968&amp;rft.volume=278&amp;rft.issue=11&amp;rft.pages=630&amp;rft_id=info:pmid/5637779&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17586305-49"><b><a href="#cite_ref-pmid17586305_49-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKaplitt_MG.2C_Feigin_A.2C_Tang_C.2C_Fitzsimons_HL.2C_Mattis_P.2C_Lawlor_PA.2C_Bland_RJ.2C_Young_D.2C_Strybing_K.2C_Eidelberg_D.2C_During_MJ2007">Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D, During MJ (2007). "Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial". <i>Lancet</i> <b>369</b> (9579): 2097–105. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2807%2960982-9" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2807%2960982-9" rel="nofollow">10.1016/S0140-6736(07)60982-9</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17586305" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17586305">PMID 17586305</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Safety+and+tolerability+of+gene+therapy+with+an+adeno-associated+virus+%28AAV%29+borne+GAD+gene+for+Parkinson%27s+disease%3A+an+open+label%2C+phase+I+trial&amp;rft.jtitle=Lancet&amp;rft.aulast=Kaplitt+MG%2C+Feigin+A%2C+Tang+C%2C+Fitzsimons+HL%2C+Mattis+P%2C+Lawlor+PA%2C+Bland+RJ%2C+Young+D%2C+Strybing+K%2C+Eidelberg+D%2C+During+MJ&amp;rft.au=Kaplitt+MG%2C+Feigin+A%2C+Tang+C%2C+Fitzsimons+HL%2C+Mattis+P%2C+Lawlor+PA%2C+Bland+RJ%2C+Young+D%2C+Strybing+K%2C+Eidelberg+D%2C+During+MJ&amp;rft.date=2007&amp;rft.volume=369&amp;rft.issue=9579&amp;rft.pages=2097%E2%80%93105&amp;rft_id=info:doi/10.1016%2FS0140-6736%2807%2960982-9&amp;rft_id=info:pmid/17586305&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-50"><b><a href="#cite_ref-50" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBonuccelli_U.2C.0A_Del_Dotto_P2006">Bonuccelli U, Del Dotto P (2006). "New pharmacologic horizons in the treatment of Parkinson disease". <i>Neurology</i> <b>67</b> (2): 30–38.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=New+pharmacologic+horizons+in+the+treatment+of+Parkinson+disease&amp;rft.jtitle=Neurology&amp;rft.aulast=Bonuccelli+U%2C%0A+Del+Dotto+P&amp;rft.au=Bonuccelli+U%2C%0A+Del+Dotto+P&amp;rft.date=2006&amp;rft.volume=67&amp;rft.issue=2&amp;rft.pages=30%E2%80%9338&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-51"><b><a href="#cite_ref-51" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDjaldetti_R.2C_Melamed_E2002">Djaldetti R, Melamed E (2002). "New drugs in the future treatment of Parkinson's disease". <i>J. Neurol.</i> <b>249 Suppl 2</b>: II30–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00415-002-1206-2" class="external text" title="http://dx.doi.org/10.1007%2Fs00415-002-1206-2" rel="nofollow">10.1007/s00415-002-1206-2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12375061" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12375061">PMID 12375061</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=New+drugs+in+the+future+treatment+of+Parkinson%27s+disease&amp;rft.jtitle=J.+Neurol.&amp;rft.aulast=Djaldetti+R%2C+Melamed+E&amp;rft.au=Djaldetti+R%2C+Melamed+E&amp;rft.date=2002&amp;rft.volume=249+Suppl+2&amp;rft.pages=II30%E2%80%935&amp;rft_id=info:doi/10.1007%2Fs00415-002-1206-2&amp;rft_id=info:pmid/12375061&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-PSG_1993-52">^ <a href="#cite_ref-PSG_1993_52-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PSG_1993_52-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFThe_Parkinson_Study_Group.2C1993">The Parkinson Study Group, (1993). "Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. The Parkinson Study Group". <i>N. Engl. J. Med.</i> <b>328</b> (3): 176–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM199301213280305" class="external text" title="http://dx.doi.org/10.1056%2FNEJM199301213280305" rel="nofollow">10.1056/NEJM199301213280305</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8417384" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8417384">PMID 8417384</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+tocopherol+and+deprenyl+on+the+progression+of+disability+in+early+Parkinson%27s+disease.+The+Parkinson+Study+Group&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=The+Parkinson+Study+Group%2C&amp;rft.au=The+Parkinson+Study+Group%2C&amp;rft.date=1993&amp;rft.volume=328&amp;rft.issue=3&amp;rft.pages=176%E2%80%9383&amp;rft_id=info:doi/10.1056%2FNEJM199301213280305&amp;rft_id=info:pmid/8417384&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17631864-53"><b><a href="#cite_ref-pmid17631864_53-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFQuik_M.2C_Bordia_T.2C_O.27Leary_K2007">Quik M, Bordia T, O'Leary K (2007). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=2046219" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=2046219" rel="nofollow">Nicotinic receptors as CNS targets for Parkinson's disease</a>". <i>Biochem. Pharmacol.</i> <b>74</b> (8): 1224–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.bcp.2007.06.015" class="external text" title="http://dx.doi.org/10.1016%2Fj.bcp.2007.06.015" rel="nofollow">10.1016/j.bcp.2007.06.015</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17631864" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17631864">PMID 17631864</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Nicotinic+receptors+as+CNS+targets+for+Parkinson%27s+disease&amp;rft.jtitle=Biochem.+Pharmacol.&amp;rft.aulast=Quik+M%2C+Bordia+T%2C+O%27Leary+K&amp;rft.au=Quik+M%2C+Bordia+T%2C+O%27Leary+K&amp;rft.date=2007&amp;rft.volume=74&amp;rft.issue=8&amp;rft.pages=1224%E2%80%9334&amp;rft_id=info:doi/10.1016%2Fj.bcp.2007.06.015&amp;rft_id=info:pmid/17631864&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-54"><b><a href="#cite_ref-54" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFreed_CR.2C_Greene_PE.2C_Breeze_RE.2C_.27.27et_al.27.272001">Freed CR, Greene PE, Breeze RE, <i>et al</i> (2001). "Transplantation of embryonic dopamine neurons for severe Parkinson's disease". <i>N. Engl. J. Med.</i> <b>344</b> (10): 710–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM200103083441002" class="external text" title="http://dx.doi.org/10.1056%2FNEJM200103083441002" rel="nofollow">10.1056/NEJM200103083441002</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11236774" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11236774">PMID 11236774</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Transplantation+of+embryonic+dopamine+neurons+for+severe+Parkinson%27s+disease&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Freed+CR%2C+Greene+PE%2C+Breeze+RE%2C+%27%27et+al%27%27&amp;rft.au=Freed+CR%2C+Greene+PE%2C+Breeze+RE%2C+%27%27et+al%27%27&amp;rft.date=2001&amp;rft.volume=344&amp;rft.issue=10&amp;rft.pages=710%E2%80%939&amp;rft_id=info:doi/10.1056%2FNEJM200103083441002&amp;rft_id=info:pmid/11236774&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-55"><b><a href="#cite_ref-55" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRedmond_DE2002">Redmond DE (2002). "Cellular replacement therapy for Parkinson's disease--where we are today?". <i>The Neuroscientist&#160;: a review journal bringing neurobiology, neurology and psychiatry</i> <b>8</b> (5): 457–88. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12374430" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12374430">PMID 12374430</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cellular+replacement+therapy+for+Parkinson%27s+disease--where+we+are+today%3F&amp;rft.jtitle=The+Neuroscientist+%3A+a+review+journal+bringing+neurobiology%2C+neurology+and+psychiatry&amp;rft.aulast=Redmond+DE&amp;rft.au=Redmond+DE&amp;rft.date=2002&amp;rft.volume=8&amp;rft.issue=5&amp;rft.pages=457%E2%80%9388&amp;rft_id=info:pmid/12374430&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-56"><b><a href="#cite_ref-56" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRedmond_E_et_al2007">Redmond E et al (2007). "Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells". <i>Proceedings of the National Academy of Sciences</i> <b>104</b> (29): 12175. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1073%2Fpnas.0704091104" class="external text" title="http://dx.doi.org/10.1073%2Fpnas.0704091104" rel="nofollow">10.1073/pnas.0704091104</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17586681" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17586681">PMID 17586681</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Behavioral+improvement+in+a+primate+Parkinson%27s+model+is+associated+with+multiple+homeostatic+effects+of+human+neural+stem+cells&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences&amp;rft.aulast=Redmond+E+et+al&amp;rft.au=Redmond+E+et+al&amp;rft.date=2007&amp;rft.volume=104&amp;rft.issue=29&amp;rft.pages=12175&amp;rft_id=info:doi/10.1073%2Fpnas.0704091104&amp;rft_id=info:pmid/17586681&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-57"><b><a href="#cite_ref-57" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLemoine_P.2C_Robelin_N.2C_Sebert_P.2C_Mouret_J1986">Lemoine P, Robelin N, Sebert P, Mouret J (1986). "La L-tyrosine&#160;: traitement au long cours de la maladie de Parkinson [L-tyrosine&#160;: A long term treatment of Parkinson's Disease]" (in French). <i>Comptes rendus academie des sciences</i> <b>309</b>: 43–47.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=La+L-tyrosine+%3A+traitement+au+long+cours+de+la+maladie+de+Parkinson+%5BL-tyrosine+%3A+A+long+term+treatment+of+Parkinson%27s+Disease%5D&amp;rft.jtitle=Comptes+rendus+academie+des+sciences&amp;rft.aulast=Lemoine+P%2C+Robelin+N%2C+Sebert+P%2C+Mouret+J&amp;rft.au=Lemoine+P%2C+Robelin+N%2C+Sebert+P%2C+Mouret+J&amp;rft.date=1986&amp;rft.volume=309&amp;rft.pages=43%E2%80%9347&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-58"><b><a href="#cite_ref-58" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBirkmayer_W.2C_Birkmayer_JG1986">Birkmayer W, Birkmayer JG (1986). "<a href="http://www.springerlink.com/link.asp?id=tp15r2g8u6327731" class="external text" title="http://www.springerlink.com/link.asp?id=tp15r2g8u6327731" rel="nofollow">Iron, a new aid in the treatment of Parkinson patients</a>". <i>J. Neural Transm.</i> <b>67</b> (3-4): 287–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2FBF01243354" class="external text" title="http://dx.doi.org/10.1007%2FBF01243354" rel="nofollow">10.1007/BF01243354</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3806082" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/3806082">PMID 3806082</a><span class="printonly">. <a href="http://www.springerlink.com/link.asp?id=tp15r2g8u6327731" class="external free" title="http://www.springerlink.com/link.asp?id=tp15r2g8u6327731" rel="nofollow">http://www.springerlink.com/link.asp?id=tp15r2g8u6327731</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Iron%2C+a+new+aid+in+the+treatment+of+Parkinson+patients&amp;rft.jtitle=J.+Neural+Transm.&amp;rft.aulast=Birkmayer+W%2C+Birkmayer+JG&amp;rft.au=Birkmayer+W%2C+Birkmayer+JG&amp;rft.date=1986&amp;rft.volume=67&amp;rft.issue=3-4&amp;rft.pages=287%E2%80%9392&amp;rft_id=info:doi/10.1007%2FBF01243354&amp;rft_id=info:pmid/3806082&amp;rft_id=http%3A%2F%2Fwww.springerlink.com%2Flink.asp%3Fid%3Dtp15r2g8u6327731&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-59"><b><a href="#cite_ref-59" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFEditors_Przuntek_H_.2C_Riederer_P1989">Editors Przuntek H , Riederer P, ed (1989). <i>Early diagnosis and preventive therapy in Parkinson's disease</i>. Springer. p.&#160;323. <a href="/wiki/Special:BookSources/0387820809" class="internal">ISBN 0-387-82080-9</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Early+diagnosis+and+preventive+therapy+in+Parkinson%27s+disease&amp;rft.date=1989&amp;rft.pages=p.%26nbsp%3B323&amp;rft.pub=Springer&amp;rft.isbn=0-387-82080-9&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-60"><b><a href="#cite_ref-60" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://home.uchicago.edu/~syin/Kang.doc" class="external text" title="http://home.uchicago.edu/~syin/Kang.doc" rel="nofollow">"Dopamine biosynthesis"</a> (Word doc). University of Chicago Personal Web Pages<span class="printonly">. <a href="http://home.uchicago.edu/~syin/Kang.doc" class="external free" title="http://home.uchicago.edu/~syin/Kang.doc" rel="nofollow">http://home.uchicago.edu/~syin/Kang.doc</a></span><span class="reference-accessdate">. Retrieved on 2006-11-04</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Dopamine+biosynthesis&amp;rft.atitle=&amp;rft.pub=University+of+Chicago+Personal+Web+Pages&amp;rft_id=http%3A%2F%2Fhome.uchicago.edu%2F%7Esyin%2FKang.doc&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-61"><b><a href="#cite_ref-61" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKatzenschlager_R.2C_Evans_A.2C_Manson_A.2C_.27.27et_al.27.272004">Katzenschlager R, Evans A, Manson A, <i>et al</i> (2004). "Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study". <i>J. Neurol. Neurosurg. Psychiatr.</i> <b>75</b> (12): 1672–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjnnp.2003.028761" class="external text" title="http://dx.doi.org/10.1136%2Fjnnp.2003.028761" rel="nofollow">10.1136/jnnp.2003.028761</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15548480" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15548480">PMID 15548480</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mucuna+pruriens+in+Parkinson%27s+disease%3A+a+double+blind+clinical+and+pharmacological+study&amp;rft.jtitle=J.+Neurol.+Neurosurg.+Psychiatr.&amp;rft.aulast=Katzenschlager+R%2C+Evans+A%2C+Manson+A%2C+%27%27et+al%27%27&amp;rft.au=Katzenschlager+R%2C+Evans+A%2C+Manson+A%2C+%27%27et+al%27%27&amp;rft.date=2004&amp;rft.volume=75&amp;rft.issue=12&amp;rft.pages=1672%E2%80%937&amp;rft_id=info:doi/10.1136%2Fjnnp.2003.028761&amp;rft_id=info:pmid/15548480&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-62"><b><a href="#cite_ref-62" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFManyam.2C_B..2C_Dhanasekaran.2C_M..2C_Hare.2C_T.2004">Manyam, B., Dhanasekaran, M., Hare, T. (2004). "Neuroprotective effects of the antiparkinson drug <i>Mucuna pruriens</i>". <i>J. Phytotherapy Research</i> <b>18</b> (9): 706–712. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fptr.1514" class="external text" title="http://dx.doi.org/10.1002%2Fptr.1514" rel="nofollow">10.1002/ptr.1514</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Neuroprotective+effects+of+the+antiparkinson+drug+%27%27Mucuna+pruriens%27%27&amp;rft.jtitle=J.+Phytotherapy+Research&amp;rft.aulast=Manyam%2C+B.%2C+Dhanasekaran%2C+M.%2C+Hare%2C+T.&amp;rft.au=Manyam%2C+B.%2C+Dhanasekaran%2C+M.%2C+Hare%2C+T.&amp;rft.date=2004&amp;rft.volume=18&amp;rft.issue=9&amp;rft.pages=706%E2%80%93712&amp;rft_id=info:doi/10.1002%2Fptr.1514&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-63"><b><a href="#cite_ref-63" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSchmitz-Hubsch_T2006">Schmitz-Hubsch T (2006). "Qigong exercise for the symptoms of Parkinson's disease: a randomized, controlled pilot study". <i>Mov Disord</i> <b>21</b> (4): 543–548. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2Fmds.20705" class="external text" title="http://dx.doi.org/10.1002%2Fmds.20705" rel="nofollow">10.1002/mds.20705</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16229022" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16229022">PMID 16229022</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Qigong+exercise+for+the+symptoms+of+Parkinson%27s+disease%3A+a+randomized%2C+controlled+pilot+study&amp;rft.jtitle=Mov+Disord&amp;rft.aulast=Schmitz-Hubsch+T&amp;rft.au=Schmitz-Hubsch+T&amp;rft.date=2006&amp;rft.volume=21&amp;rft.issue=4&amp;rft.pages=543%E2%80%93548&amp;rft_id=info:doi/10.1002%2Fmds.20705&amp;rft_id=info:pmid/16229022&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-64"><b><a href="#cite_ref-64" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBurini_D.2C_Farabollini_B.2C_Iacucci_S.2C_.27.27et_al.27.272006">Burini D, Farabollini B, Iacucci S, <i>et al</i> (2006). "A randomised controlled cross-over trial of aerobic training versus qigong in advanced Parkinson's disease". <i>Europa medicophysica</i> <b>42</b> (3): 231–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17039221" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17039221">PMID 17039221</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+randomised+controlled+cross-over+trial+of+aerobic+training+versus+qigong+in+advanced+Parkinson%27s+disease&amp;rft.jtitle=Europa+medicophysica&amp;rft.aulast=Burini+D%2C+Farabollini+B%2C+Iacucci+S%2C+%27%27et+al%27%27&amp;rft.au=Burini+D%2C+Farabollini+B%2C+Iacucci+S%2C+%27%27et+al%27%27&amp;rft.date=2006&amp;rft.volume=42&amp;rft.issue=3&amp;rft.pages=231%E2%80%938&amp;rft_id=info:pmid/17039221&amp;rfr_id=info:sid/en.wikipedia.org:Parkinson%27s_disease"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="mw-headline">External links</span></h2>
<table class="metadata plainlinks mbox-small" style="border:1px solid #aaa; background-color:#f9f9f9;">
<tr>
<td class="mbox-image"><a href="http://commons.wikimedia.org/wiki/Special:Search/Parkinson%27s_disease" title="commons:Special:Search/Parkinson's disease"><img alt="Sister project" src="http://upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/40px-Commons-logo.svg.png" width="40" height="54" border="0" /></a></td>
<td class="mbox-text" style=""><a href="/wiki/Wikimedia_Commons" title="Wikimedia Commons">Wikimedia Commons</a> has media related to: <b><i><a href="http://commons.wikimedia.org/wiki/Category:Parkinson%27s_disease" class="extiw" title="commons:Category:Parkinson's disease">Parkinson's disease</a> </i></b></td>
</tr>
</table>
<table class="metadata plainlinks mbox-small" style="border:1px solid #aaa; background-color:#f9f9f9;">
<tr>
<td class="mbox-image"><a href="http://en.wikibooks.org/wiki/Special:Search/Parkinson%27s_disease" title="b:Special:Search/Parkinson's disease"><img alt="Sister project" src="http://upload.wikimedia.org/wikipedia/commons/thumb/d/df/Wikibooks-logo-en-noslogan.svg/40px-Wikibooks-logo-en-noslogan.svg.png" width="40" height="40" border="0" /></a></td>
<td class="mbox-text" style=""><a href="/wiki/Wikibooks" title="Wikibooks">Wikibooks</a> has a book on the topic of
<div style="margin-left:10px;"><i><b><a href="http://en.wikibooks.org/wiki/Speech-Language_Pathology" class="extiw" title="wikibooks:Speech-Language Pathology">Speech-Language Pathology</a></b></i></div>
</td>
</tr>
</table>
<ul>
<li><a href="http://www.epda.eu.com/" class="external text" title="http://www.epda.eu.com/" rel="nofollow">European Parkinson's Disease Association</a></li>
<li><a href="http://www.dmoz.org/Health/Conditions_and_Diseases/Neurological_Disorders/Parkinson's_Disease//" class="external text" title="http://www.dmoz.org/Health/Conditions_and_Diseases/Neurological_Disorders/Parkinson's_Disease//" rel="nofollow">Parkinson's Disease</a> at the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><a href="http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm" class="external text" title="http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm" rel="nofollow">Parkinson's Disease: Hope Through Research (National Institute of Neurological Disorders and Stroke)</a></li>
<li><a href="http://www.wpda.org/" class="external text" title="http://www.wpda.org/" rel="nofollow">World Parkinson Disease Association</a></li>
</ul>
<p><br /></p>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible collapsed" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Mental_and_behavioral_disorders" title="Template:Mental and behavioral disorders"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Mental_and_behavioral_disorders" title="Template talk:Mental and behavioral disorders"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Mental_and_behavioral_disorders&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Mental_and_behavioral_disorders&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/ICD-10" title="ICD-10">WHO ICD-10</a> <a href="/wiki/Mental_disorder" title="Mental disorder">mental</a> and <a href="/wiki/Emotional_and_behavioral_disorders" title="Emotional and behavioral disorders">behavioral disorders</a> (<a href="/wiki/ICD-10_Chapter_V:_Mental_and_behavioural_disorders" title="ICD-10 Chapter V: Mental and behavioural disorders">F</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/List_of_ICD-9_codes_290-319:_Mental_disorders" title="List of ICD-9 codes 290-319: Mental disorders" class="mw-redirect">290–319</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;">Neurological/symptomatic</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Dementia" title="Dementia">Dementia</a> (<a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a>, <a href="/wiki/Multi-infarct_dementia" title="Multi-infarct dementia">multi-infarct dementia</a>, <a href="/wiki/Pick%27s_disease" title="Pick's disease">Pick's disease</a>, <a href="/wiki/Creutzfeldt-Jakob_disease" title="Creutzfeldt-Jakob disease">Creutzfeldt-Jakob disease</a>, <a href="/wiki/Huntington%27s_disease" title="Huntington's disease">Huntington's disease</a>, <strong class="selflink">Parkinson's disease</strong>, <a href="/wiki/AIDS_dementia_complex" title="AIDS dementia complex">AIDS dementia complex</a>, <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">Frontotemporal dementia</a>, <a href="/wiki/Wandering_(dementia)" title="Wandering (dementia)">Elopement</a>, <a href="/wiki/Sundowning_(dementia)" title="Sundowning (dementia)">Sundowning</a>, <a href="/wiki/Wandering_(dementia)" title="Wandering (dementia)">Wandering</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Delirium" title="Delirium">Delirium</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Post-concussion_syndrome" title="Post-concussion syndrome">Post-concussion syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Organic_brain_syndrome" title="Organic brain syndrome">Organic brain syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Psychoactive" title="Psychoactive" class="mw-redirect">Psychoactive</a> substance</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Alcohol" title="Alcohol">alcohol</a></i> (<a href="/wiki/Acute_alcohol_intoxication" title="Acute alcohol intoxication">acute alcohol intoxication</a>, <a href="/wiki/Drunkenness" title="Drunkenness">drunkenness</a>, <a href="/wiki/Alcohol_dependence" title="Alcohol dependence">alcohol dependence</a>, <a href="/wiki/Alcoholic_hallucinosis" title="Alcoholic hallucinosis">alcoholic hallucinosis</a>, <a href="/wiki/Alcohol_withdrawal" title="Alcohol withdrawal" class="mw-redirect">Alcohol withdrawal</a>, <a href="/wiki/Delirium_tremens" title="Delirium tremens">delirium tremens</a>, <a href="/wiki/Korsakoff%27s_syndrome" title="Korsakoff's syndrome">Korsakoff's syndrome</a>, <a href="/wiki/Alcohol_abuse" title="Alcohol abuse">alcohol abuse</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Opioid" title="Opioid">opioids</a></i> (<a href="/wiki/Opioid_overdose" title="Opioid overdose">opioid overdose</a>, <a href="/wiki/Opioid_dependency" title="Opioid dependency">opioid dependency</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Sedative" title="Sedative">sedative</a>/<a href="/wiki/Hypnotic" title="Hypnotic">hypnotic</a></i> (<a href="/wiki/Benzodiazepine_overdose" title="Benzodiazepine overdose">benzodiazepine overdose</a>, <a href="/wiki/Benzodiazepine_dependence" title="Benzodiazepine dependence">benzodiazepine dependence</a>, <a href="/wiki/Benzodiazepine_withdrawal" title="Benzodiazepine withdrawal" class="mw-redirect">benzodiazepine withdrawal</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Cocaine" title="Cocaine">cocaine</a></i> (<a href="/wiki/Cocaine_dependence" title="Cocaine dependence">cocaine dependence</a>)<span style="font-weight:bold;">&#160;·</span> <i>general</i> (<a href="/wiki/Intoxication" title="Intoxication">Intoxication</a>/<a href="/wiki/Drug_overdose" title="Drug overdose">Drug overdose</a>, <a href="/wiki/Drug_abuse" title="Drug abuse">Drug abuse</a>, <a href="/wiki/Physical_dependence" title="Physical dependence">Physical dependence</a>, <a href="/wiki/Rebound_effect" title="Rebound effect">Rebound effect</a>, <a href="/wiki/Withdrawal" title="Withdrawal">Withdrawal</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Schizophrenia" title="Schizophrenia">Schizophrenia</a>, <a href="/wiki/Schizotypal" title="Schizotypal" class="mw-redirect">schizotypal</a><br />
and <a href="/wiki/Delusional" title="Delusional" class="mw-redirect">delusional</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Psychosis" title="Psychosis">Psychosis</a> (<a href="/wiki/Schizoaffective_disorder" title="Schizoaffective disorder">Schizoaffective disorder</a>, <a href="/wiki/Schizophreniform_disorder" title="Schizophreniform disorder">Schizophreniform disorder</a>, <a href="/wiki/Brief_reactive_psychosis" title="Brief reactive psychosis">Brief reactive psychosis</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Schizophrenia" title="Schizophrenia">Schizophrenia</a> (<a href="/wiki/Disorganized_schizophrenia" title="Disorganized schizophrenia">Disorganized schizophrenia</a>, <a href="/wiki/Delusional_disorder" title="Delusional disorder">Delusional disorder</a>, <a href="/wiki/Folie_%C3%A0_deux" title="Folie à deux">Folie à deux</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Personality_disorder" title="Personality disorder">Personality disorder</a> (<a href="/wiki/Schizotypal_personality_disorder" title="Schizotypal personality disorder">Schizotypal personality disorder</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Mood_disorder" title="Mood disorder">Mood</a> (affective)</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Mania" title="Mania">Mania</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">Bipolar disorder</a> (<a href="/wiki/Bipolar_I_disorder" title="Bipolar I disorder">Bipolar I</a>, <a href="/wiki/Bipolar_II_disorder" title="Bipolar II disorder">Bipolar II</a>, <a href="/wiki/Cyclothymia" title="Cyclothymia">Cyclothymia</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Types_of_psychological_depression" title="Types of psychological depression">Depression</a> (<a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">Major depressive disorder</a>, <a href="/wiki/Dysthymia" title="Dysthymia">Dysthymia</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Neurotic" title="Neurotic" class="mw-redirect">Neurotic</a>, <a href="/wiki/Stress_(medicine)" title="Stress (medicine)" class="mw-redirect">stress</a>-related<br />
and <a href="/wiki/Somatoform" title="Somatoform" class="mw-redirect">somatoform</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Anxiety_disorder" title="Anxiety disorder">Anxiety disorder</a>/<br />
<a href="/wiki/Adjustment_disorder" title="Adjustment disorder">adjustment disorder</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>phobic anxiety disorders:</i> <a href="/wiki/Agoraphobia" title="Agoraphobia">Agoraphobia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Social_anxiety" title="Social anxiety">Social anxiety</a>/<a href="/wiki/Social_phobia" title="Social phobia">Social phobia</a> (<a href="/wiki/Anthropophobia" title="Anthropophobia">Anthropophobia</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Specific_phobia" title="Specific phobia">Specific phobia</a> (<a href="/wiki/Claustrophobia" title="Claustrophobia">Claustrophobia</a>)<br />
<a href="/wiki/Panic_disorder" title="Panic disorder">Panic disorder</a>/<a href="/wiki/Panic_attack" title="Panic attack">Panic attack</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Generalized_anxiety_disorder" title="Generalized anxiety disorder">Generalized anxiety disorder</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Obsessive-compulsive_disorder" title="Obsessive-compulsive disorder">OCD</a><span style="font-weight:bold;">&#160;·</span> <i>stress</i> (<a href="/wiki/Acute_stress_reaction" title="Acute stress reaction">Acute stress reaction</a>, <a href="/wiki/Post-traumatic_stress_disorder" title="Post-traumatic stress disorder" class="mw-redirect">PTSD</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Somatoform_disorder" title="Somatoform disorder">Somatoform disorder</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Somatization_disorder" title="Somatization disorder">Somatization disorder</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Body_dysmorphic_disorder" title="Body dysmorphic disorder">Body dysmorphic disorder</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypochondriasis" title="Hypochondriasis">Hypochondriasis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Nosophobia" title="Nosophobia">Nosophobia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Da_Costa%27s_syndrome" title="Da Costa's syndrome">Da Costa's syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Psychogenic_pain" title="Psychogenic pain">Psychalgia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Conversion_disorder" title="Conversion disorder">Conversion disorder</a> (<a href="/wiki/Ganser_syndrome" title="Ganser syndrome">Ganser syndrome</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Neurasthenia" title="Neurasthenia">Neurasthenia</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dissociative_disorder" title="Dissociative disorder">Dissociative disorder</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Dissociative_identity_disorder" title="Dissociative identity disorder">Dissociative identity disorder</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Psychogenic_amnesia" title="Psychogenic amnesia">Psychogenic amnesia</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;">Physiological/physical<br />
behavioral</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Eating_disorder" title="Eating disorder">Eating disorder</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Anorexia_nervosa" title="Anorexia nervosa">Anorexia nervosa</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Bulimia_nervosa" title="Bulimia nervosa">Bulimia nervosa</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sleep_disorder" title="Sleep disorder">Sleep disorder</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Dyssomnia" title="Dyssomnia">Dyssomnia</a> (<a href="/wiki/Hypersomnia" title="Hypersomnia">Hypersomnia</a>, <a href="/wiki/Insomnia" title="Insomnia">Insomnia</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Parasomnia" title="Parasomnia">Parasomnia</a> (<a href="/wiki/Rapid_eye_movement_behavior_disorder" title="Rapid eye movement behavior disorder">REM behavior disorder</a>, <a href="/wiki/Night_terror" title="Night terror">Night terror</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Nightmare" title="Nightmare">Nightmare</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">Sexual dysfunction</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">Erectile dysfunction</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Premature_ejaculation" title="Premature ejaculation">Premature ejaculation</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Vaginismus" title="Vaginismus">Vaginismus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Dyspareunia" title="Dyspareunia">Dyspareunia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypersexuality" title="Hypersexuality" class="mw-redirect">Hypersexuality</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Female_sexual_arousal_disorder" title="Female sexual arousal disorder">Female sexual arousal disorder</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Postnatal</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Postpartum_depression" title="Postpartum depression">Postpartum depression</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Postnatal_psychosis" title="Postnatal psychosis" class="mw-redirect">Postnatal psychosis</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;">Adult personality<br />
and behavior</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Personality_disorder" title="Personality disorder">Personality disorder</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Impulse_control_disorder" title="Impulse control disorder">Impulse control disorder</a> (<a href="/wiki/Kleptomania" title="Kleptomania">Kleptomania</a>, <a href="/wiki/Trichotillomania" title="Trichotillomania">Trichotillomania</a>, <a href="/wiki/Pyromania" title="Pyromania">Pyromania</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Factitious_disorder" title="Factitious disorder">Factitious disorder</a> (<a href="/wiki/Munchausen_syndrome" title="Munchausen syndrome" class="mw-redirect">Munchausen syndrome</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ego-dystonic_sexual_orientation" title="Ego-dystonic sexual orientation">Ego-dystonic sexual orientation</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Paraphilia" title="Paraphilia">Paraphilia</a> (<a href="/wiki/Voyeurism" title="Voyeurism">Voyeurism</a>, <a href="/wiki/Sexual_Fetishism" title="Sexual Fetishism" class="mw-redirect">Fetishism</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Mental_disorders_diagnosed_in_childhood" title="Mental disorders diagnosed in childhood">Mental disorders<br />
diagnosed in childhood</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Mental_retardation" title="Mental retardation">Mental retardation</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/X-Linked_mental_retardation" title="X-Linked mental retardation">X-Linked mental retardation</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Psychological development<br />
(<a href="/wiki/Developmental_disorder" title="Developmental disorder">developmental disorder</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Specific_developmental_disorder" title="Specific developmental disorder">Specific</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Speech_disorder" title="Speech disorder">speech</a> and language</i> (<a href="/wiki/Expressive_language_disorder" title="Expressive language disorder">expressive language disorder</a>, <a href="/wiki/Aphasia" title="Aphasia">aphasia</a>, <a href="/wiki/Expressive_aphasia" title="Expressive aphasia">expressive aphasia</a>, <a href="/wiki/Receptive_aphasia" title="Receptive aphasia">receptive aphasia</a>, <a href="/wiki/Landau-Kleffner_syndrome" title="Landau-Kleffner syndrome">Landau-Kleffner syndrome</a>, <a href="/wiki/Lisp" title="Lisp">lisp</a>)<span style="font-weight:bold;">&#160;·</span> <i>Scholastic skills</i> (<a href="/wiki/Dyslexia" title="Dyslexia">dyslexia</a>, <a href="/wiki/Dysgraphia" title="Dysgraphia">dysgraphia</a>, <a href="/wiki/Gerstmann_syndrome" title="Gerstmann syndrome">Gerstmann syndrome</a>)<span style="font-weight:bold;">&#160;·</span> <i>Motor function</i> (<a href="/wiki/Developmental_dyspraxia" title="Developmental dyspraxia">developmental dyspraxia</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pervasive_developmental_disorder" title="Pervasive developmental disorder">Pervasive</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Autism" title="Autism">Autism</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Rett_syndrome" title="Rett syndrome">Rett syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Asperger_syndrome" title="Asperger syndrome">Asperger syndrome</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Behavioral and emotional</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Attention-deficit_hyperactivity_disorder" title="Attention-deficit hyperactivity disorder">ADHD</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Conduct_disorder" title="Conduct disorder">Conduct disorder</a> (<a href="/wiki/Oppositional_defiant_disorder" title="Oppositional defiant disorder">ODD</a>)<span style="font-weight:bold;">&#160;·</span> <i>emotional disorder</i> (<a href="/wiki/Separation_anxiety_disorder" title="Separation anxiety disorder">Separation anxiety disorder</a>)<span style="font-weight:bold;">&#160;·</span> <i>social functioning</i> (<a href="/wiki/Selective_mutism" title="Selective mutism">Selective mutism</a>, <a href="/wiki/Reactive_attachment_disorder" title="Reactive attachment disorder">RAD</a>, <a href="/wiki/Disinhibited_attachment_disorder" title="Disinhibited attachment disorder">DAD</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tic_disorder" title="Tic disorder">Tic disorder</a> (<a href="/wiki/Tourette_syndrome" title="Tourette syndrome">Tourette syndrome</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Speech_disorder" title="Speech disorder">Speech</a></i> (<a href="/wiki/Stuttering" title="Stuttering">Stuttering</a>, <a href="/wiki/Cluttering" title="Cluttering">Cluttering</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Stereotypic_movement_disorder" title="Stereotypic movement disorder">Stereotypic movement disorder</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background: Silver;" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background: Silver;;border:none;; font-size:xx-small;"><a href="/wiki/Template:CNS_diseases_of_the_nervous_system" title="Template:CNS diseases of the nervous system"><span title="View this template" style=";background: Silver;;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:CNS_diseases_of_the_nervous_system" title="Template talk:CNS diseases of the nervous system"><span title="Discussion about this template" style=";background: Silver;;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:CNS_diseases_of_the_nervous_system&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:CNS_diseases_of_the_nervous_system&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background: Silver;;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Pathology" title="Pathology">Pathology</a> of the <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a>, primarily <a href="/wiki/Central_nervous_system_disease" title="Central nervous system disease">CNS</a> (<a href="/wiki/ICD-10_Chapter_VI:_Diseases_of_the_nervous_system" title="ICD-10 Chapter VI: Diseases of the nervous system">G00–G47</a>, <a href="/wiki/List_of_ICD-9_codes_320-359:_Diseases_of_the_nervous_system" title="List of ICD-9 codes 320-359: Diseases of the nervous system" class="mw-redirect">320–349</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Brain" title="Brain">Brain</a>/<br />
<a href="/wiki/Encephalopathy" title="Encephalopathy">encephalopathy</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Inflammatory" title="Inflammatory" class="mw-redirect">Inflammatory</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Encephalitis" title="Encephalitis">Encephalitis</a> (<a href="/wiki/Viral_encephalitis" title="Viral encephalitis">Viral encephalitis</a>, <a href="/wiki/Herpesviral_encephalitis" title="Herpesviral encephalitis">Herpesviral encephalitis</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cavernous_sinus_thrombosis" title="Cavernous sinus thrombosis">Cavernous sinus thrombosis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">Degenerative</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Systemic <a href="/wiki/Atrophies" title="Atrophies" class="mw-redirect">atrophies</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Huntington%27s_disease" title="Huntington's disease">Huntington's disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Spinocerebellar_ataxia" title="Spinocerebellar ataxia">Spinocerebellar ataxia</a> (<a href="/wiki/Friedreich%27s_ataxia" title="Friedreich's ataxia">Friedreich's ataxia</a>, <a href="/wiki/Ataxia_telangiectasia" title="Ataxia telangiectasia">Ataxia telangiectasia</a>, <a href="/wiki/Hereditary_spastic_paraplegia" title="Hereditary spastic paraplegia">Hereditary spastic paraplegia</a>)
<p><a href="/wiki/Spinal_muscular_atrophy" title="Spinal muscular atrophy">Spinal muscular atrophy</a>: <a href="/wiki/Kennedy_disease" title="Kennedy disease">Kennedy disease</a> <span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Spinal_muscular_atrophies_of_childhood" title="Spinal muscular atrophies of childhood">spinal muscular atrophies of childhood</a></i> (<a href="/wiki/Werdnig-Hoffman_disease" title="Werdnig-Hoffman disease">Werdnig-Hoffman</a>, <a href="/wiki/Kugelberg-Welander_disease" title="Kugelberg-Welander disease">Kugelberg-Welander</a>)</p>
<a href="/wiki/Motor_neurone_disease" title="Motor neurone disease">MND</a> (<a href="/wiki/Amyotrophic_lateral_sclerosis" title="Amyotrophic lateral sclerosis">ALS</a>, <a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">PMA</a>, <a href="/wiki/Progressive_bulbar_palsy" title="Progressive bulbar palsy">PBP</a>, <a href="/wiki/Pseudobulbar_palsy" title="Pseudobulbar palsy">PP</a>, <a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">PLS</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Fazio-Londe_disease" title="Fazio-Londe disease">Fazio-Londe</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Extrapyramidal" title="Extrapyramidal" class="mw-redirect">Extrapyramidal</a> and<br />
<a href="/wiki/Movement_disorder" title="Movement disorder">movement disorders</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Basal_ganglia_disease" title="Basal ganglia disease">Basal ganglia disease</a>: <a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a> (<strong class="selflink">Parkinson's disease</strong>, <a href="/wiki/Postencephalitic_parkinsonism" title="Postencephalitic parkinsonism">Postencephalitic parkinsonism</a>) <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">Neuroleptic malignant syndrome</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Pantothenate_kinase-associated_neurodegeneration" title="Pantothenate kinase-associated neurodegeneration">Pantothenate kinase-associated neurodegeneration</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">Progressive supranuclear palsy</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Striatonigral_degeneration" title="Striatonigral degeneration" class="mw-redirect">Striatonigral degeneration</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hemiballismus" title="Hemiballismus">Hemiballismus</a><br />
<p><a href="/wiki/Dyskinesia" title="Dyskinesia">Dyskinesia</a>: <a href="/wiki/Dystonia" title="Dystonia">Dystonia</a> (<a href="/wiki/Spasmodic_torticollis" title="Spasmodic torticollis">Spasmodic torticollis</a>, <a href="/wiki/Meige%27s_syndrome" title="Meige's syndrome">Meige's</a>, <a href="/wiki/Blepharospasm" title="Blepharospasm">Blepharospasm</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Chorea_(disease)" title="Chorea (disease)">Chorea</a> (<a href="/wiki/Choreoathetosis" title="Choreoathetosis">Choreoathetosis</a>) <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Myoclonus" title="Myoclonus">Myoclonus</a> (<a href="/wiki/Myoclonic_epilepsy" title="Myoclonic epilepsy">Myoclonic epilepsy</a>)</p>
<a href="/wiki/Essential_tremor" title="Essential tremor">Essential tremor</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">Restless legs</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Stiff_person_syndrome" title="Stiff person syndrome">Stiff person</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dementia" title="Dementia">Dementia</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's</a> (<a href="/wiki/Early-onset_Alzheimer%27s_disease" title="Early-onset Alzheimer's disease">Early-onset</a>) <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">Frontotemporal dementia</a>/<a href="/wiki/Frontotemporal_lobar_degeneration" title="Frontotemporal lobar degeneration">Frontotemporal lobar degeneration</a> (<a href="/wiki/Pick%27s_disease" title="Pick's disease">Pick's</a>, <a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">Dementia with Lewy bodies</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Multi-infarct_dementia" title="Multi-infarct dementia">Multi-infarct dementia</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Mitochondrial_disease" title="Mitochondrial disease">Mitochondrial disease</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Leigh%27s_disease" title="Leigh's disease">Leigh's</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Demyelinating_disease" title="Demyelinating disease">Demyelinating</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/CNS_demyelinating_autoimmune_diseases" title="CNS demyelinating autoimmune diseases">autoimmune</a></i> (<a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">Multiple sclerosis</a>, <a href="/wiki/Neuromyelitis_optica" title="Neuromyelitis optica">Neuromyelitis optica</a>, <a href="/wiki/Schilder%27s_disease" title="Schilder's disease">Schilder's disease</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Hereditary_CNS_demyelinating_disease" title="Hereditary CNS demyelinating disease">hereditary</a></i> (<a href="/wiki/Adrenoleukodystrophy" title="Adrenoleukodystrophy">Adrenoleukodystrophy</a>, <a href="/wiki/Alexander_disease" title="Alexander disease">Alexander</a>, <a href="/wiki/Canavan_disease" title="Canavan disease">Canavan</a>, <a href="/wiki/Krabbe_disease" title="Krabbe disease">Krabbe</a>, <a href="/wiki/Metachromatic_leukodystrophy" title="Metachromatic leukodystrophy">ML</a>, <a href="/wiki/Pelizaeus-Merzbacher_disease" title="Pelizaeus-Merzbacher disease">Pelizaeus-Merzbacher</a>, <a href="/wiki/Leukoencephalopathy_with_vanishing_white_matter" title="Leukoencephalopathy with vanishing white matter">VWM</a>, <a href="/wiki/Megalencephalic_leukoencephalopathy_with_subcortical_cysts" title="Megalencephalic leukoencephalopathy with subcortical cysts">MFC</a>, <a href="/wiki/CAMFAK_syndrome" title="CAMFAK syndrome">CAMFAK syndrome</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Central_pontine_myelinolysis" title="Central pontine myelinolysis">Central pontine myelinolysis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Marchiafava-Bignami_disease" title="Marchiafava-Bignami disease">Marchiafava-Bignami disease</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Alpers%27_disease" title="Alpers' disease">Alpers'</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Episodic/<br />
<a href="/wiki/Paroxysm" title="Paroxysm" class="mw-redirect">paroxysmal</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Epileptic_seizure" title="Epileptic seizure" class="mw-redirect">Seizure</a>/<a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Focal_seizures" title="Focal seizures" class="mw-redirect">Focal</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Generalised_epilepsy" title="Generalised epilepsy">Generalised</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Status_epilepticus" title="Status epilepticus">Status epilepticus</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Myoclonic_epilepsy" title="Myoclonic epilepsy">Myoclonic epilepsy</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Headache" title="Headache">Headache</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Migraine" title="Migraine">Migraine</a> (<a href="/wiki/Familial_hemiplegic_migraine" title="Familial hemiplegic migraine">Familial hemiplegic</a>) <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cluster_headache" title="Cluster headache">Cluster</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Vascular_headache" title="Vascular headache">Vascular</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tension_headache" title="Tension headache">Tension</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Vascular_disease" title="Vascular disease">Vascular</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Transient_ischemic_attack" title="Transient ischemic attack">Transient ischemic attack</a> (<a href="/wiki/Amaurosis_fugax" title="Amaurosis fugax">Amaurosis fugax</a>, <a href="/wiki/Transient_global_amnesia" title="Transient global amnesia">Transient global amnesia</a>)<br />
<a href="/wiki/Cerebrovascular_disease" title="Cerebrovascular disease">Cerebrovascular disease</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Stroke" title="Stroke">Stroke</a> (<a href="/wiki/Middle_cerebral_artery_syndrome" title="Middle cerebral artery syndrome">MCA</a>, <a href="/wiki/Anterior_cerebral_artery_syndrome" title="Anterior cerebral artery syndrome">ACA</a>, <a href="/wiki/Posterior_cerebral_artery_syndrome" title="Posterior cerebral artery syndrome">PCA</a>, <a href="/wiki/Foville%27s_syndrome" title="Foville's syndrome">Foville's</a>, <a href="/wiki/Millard-Gubler_syndrome" title="Millard-Gubler syndrome">Millard-Gubler</a>, <a href="/wiki/Lateral_medullary_syndrome" title="Lateral medullary syndrome">Lateral medullary</a>, <a href="/wiki/Weber%27s_syndrome" title="Weber's syndrome">Weber's</a>, <a href="/wiki/Lacunar_stroke" title="Lacunar stroke">Lacunar stroke</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sleep_disorder" title="Sleep disorder">Sleep disorders</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Insomnia" title="Insomnia">Insomnia</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypersomnia" title="Hypersomnia">Hypersomnia</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sleep_apnea" title="Sleep apnea">Sleep apnea</a> (<a href="/wiki/Obstructive_sleep_apnea" title="Obstructive sleep apnea">Obstructive</a>, <a href="/wiki/Ondine%27s_curse" title="Ondine's curse">Ondine's curse</a>) <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Narcolepsy" title="Narcolepsy">Narcolepsy</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cataplexy" title="Cataplexy">Cataplexy</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Kleine-Levin_syndrome" title="Kleine-Levin syndrome">Kleine-Levin</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Circadian_rhythm_sleep_disorder" title="Circadian rhythm sleep disorder">Circadian rhythm sleep</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Delayed_sleep_phase_syndrome" title="Delayed sleep phase syndrome">Delayed sleep phase</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Advanced_sleep_phase_syndrome" title="Advanced sleep phase syndrome">Advanced sleep phase</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Other</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Intracranial_hypertension" title="Intracranial hypertension" class="mw-redirect">Intracranial hypertension</a> (<a href="/wiki/Hydrocephalus" title="Hydrocephalus">Hydrocephalus</a>/<a href="/wiki/Normal_pressure_hydrocephalus" title="Normal pressure hydrocephalus">Normal pressure</a>, <a href="/wiki/Idiopathic_intracranial_hypertension" title="Idiopathic intracranial hypertension">Idiopathic intracranial hypertension</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Brain_herniation" title="Brain herniation">Brain herniation</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cerebral_edema" title="Cerebral edema">Cerebral edema</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Reye%27s_syndrome" title="Reye's syndrome">Reye's</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">Hepatic encephalopathy</a> <span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Toxic_encephalopathy" title="Toxic encephalopathy">Toxic encephalopathy</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;"><a href="/wiki/Spinal_cord" title="Spinal cord">Spinal cord</a>/<br />
<a href="/wiki/Myelopathy" title="Myelopathy">myelopathy</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Inflammatory" title="Inflammatory" class="mw-redirect">Inflammatory</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Myelitis" title="Myelitis">Myelitis</a>: <a href="/wiki/Poliomyelitis" title="Poliomyelitis">Poliomyelitis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Demyelinating_disease" title="Demyelinating disease">Demyelinating disease</a> (<a href="/wiki/Transverse_myelitis" title="Transverse myelitis">Transverse myelitis</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tropical_spastic_paraparesis" title="Tropical spastic paraparesis">Tropical spastic paraparesis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;">Other</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Syringomyelia" title="Syringomyelia">Syringomyelia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Syringobulbia" title="Syringobulbia">Syringobulbia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Morvan%27s_syndrome" title="Morvan's syndrome">Morvan's syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Vascular_myelopathy" title="Vascular myelopathy">Vascular myelopathy</a> (<a href="/wiki/Foix-Alajouanine_syndrome" title="Foix-Alajouanine syndrome">Foix-Alajouanine syndrome</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Spinal_cord_compression" title="Spinal cord compression">Spinal cord compression</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightYellow;">Both/either</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightYellow;">
<div style="padding:0em 0.75em;"><a href="/wiki/Inflammatory" title="Inflammatory" class="mw-redirect">Inflammatory</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Encephalomyelitis" title="Encephalomyelitis">Encephalomyelitis</a> (<a href="/wiki/Acute_disseminated_encephalomyelitis" title="Acute disseminated encephalomyelitis">Acute disseminated</a>)<br />
<p><a href="/wiki/Meningitis" title="Meningitis">Meningitis</a>/<a href="/wiki/Arachnoiditis" title="Arachnoiditis">Arachnoiditis</a>: <a href="/wiki/Bacterial_meningitis" title="Bacterial meningitis">Bacterial</a> (<a href="/wiki/Tuberculous_meningitis" title="Tuberculous meningitis">Tuberculous</a>, <a href="/wiki/Haemophilus_meningitis" title="Haemophilus meningitis">Haemophilus</a>, <a href="/wiki/Pneumococcal_infection" title="Pneumococcal infection">Pneumococcal</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Viral_meningitis" title="Viral meningitis">Viral</a> (<a href="/wiki/Herpesviral_meningitis" title="Herpesviral meningitis">Herpesviral</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Fungal_meningitis" title="Fungal meningitis">Fungal</a> (<a href="/wiki/Cryptococcal_meningitis" title="Cryptococcal meningitis" class="mw-redirect">Cryptococcal</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Aseptic_meningitis" title="Aseptic meningitis">Aseptic</a> (<a href="/wiki/Drug-induced_aseptic_meningitis" title="Drug-induced aseptic meningitis">Drug-induced</a>)</p>
<a href="/wiki/Meningoencephalitis" title="Meningoencephalitis">Meningoencephalitis</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>see also <a href="/wiki/Template:Congenital_malformations_and_deformations_of_nervous_system" title="Template:Congenital malformations and deformations of nervous system">congenital</a>, <a href="/wiki/Template:Central_nervous_system_tumors" title="Template:Central nervous system tumors">tumors</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 35771/1000000
Post-expand include size: 461012/2048000 bytes
Template argument size: 240426/2048000 bytes
Expensive parser function count: 2/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:22228064-0!1!0!default!!en!2!edit=0 and timestamp 20090411145034 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Parkinson%27s_disease">http://en.wikipedia.org/wiki/Parkinson%27s_disease</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Aging-associated_diseases" title="Category:Aging-associated diseases">Aging-associated diseases</a></span> | <span dir='ltr'><a href="/wiki/Category:Geriatrics" title="Category:Geriatrics">Geriatrics</a></span> | <span dir='ltr'><a href="/wiki/Category:Parkinson%27s_disease" title="Category:Parkinson&#039;s disease">Parkinson's disease</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_April_2009" title="Category:Articles with unsourced statements since April 2009">Articles with unsourced statements since April 2009</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_August_2008" title="Category:Articles with unsourced statements since August 2008">Articles with unsourced statements since August 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_trivia_sections_from_August_2008" title="Category:Articles with trivia sections from August 2008">Articles with trivia sections from August 2008</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Parkinson%27s_disease" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Parkinson%27s_disease" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-viewsource"><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e">View source</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Parkinson%27s_disease" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Parkinson%27s_disease" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Parkinson%27s_disease" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Parkinson%27s_disease&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Parkinson%27s_disease&amp;oldid=283182698" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Parkinson%27s_disease&amp;id=283182698">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ar"><a href="http://ar.wikipedia.org/wiki/%D9%85%D8%B1%D8%B6_%D8%A8%D8%A7%D8%B1%D9%83%D9%86%D8%B3%D9%88%D9%86">العربية</a></li>
				<li class="interwiki-zh-min-nan"><a href="http://zh-min-nan.wikipedia.org/wiki/Parkinson_%C3%AA_p%C4%93%E2%81%BF">Bân-lâm-gú</a></li>
				<li class="interwiki-bg"><a href="http://bg.wikipedia.org/wiki/%D0%91%D0%BE%D0%BB%D0%B5%D1%81%D1%82_%D0%BD%D0%B0_%D0%9F%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD">Български</a></li>
				<li class="interwiki-bs"><a href="http://bs.wikipedia.org/wiki/Parkinsonova_bolest">Bosanski</a></li>
				<li class="interwiki-ca"><a href="http://ca.wikipedia.org/wiki/Malaltia_de_Parkinson">Català</a></li>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/Parkinsonova_nemoc">Česky</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Parkinsons_sygdom">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Parkinson-Krankheit">Deutsch</a></li>
				<li class="interwiki-et"><a href="http://et.wikipedia.org/wiki/Parkinsoni_t%C3%B5bi">Eesti</a></li>
				<li class="interwiki-el"><a href="http://el.wikipedia.org/wiki/%CE%9D%CF%8C%CF%83%CE%BF%CF%82_%CF%84%CE%BF%CF%85_%CE%A0%CE%AC%CF%81%CE%BA%CE%B9%CE%BD%CF%83%CE%BF%CE%BD">Ελληνικά</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Enfermedad_de_Parkinson">Español</a></li>
				<li class="interwiki-eo"><a href="http://eo.wikipedia.org/wiki/Parkinsono">Esperanto</a></li>
				<li class="interwiki-fa"><a href="http://fa.wikipedia.org/wiki/%D9%BE%D8%A7%D8%B1%DA%A9%DB%8C%D9%86%D8%B3%D9%88%D9%86">فارسی</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Maladie_de_Parkinson">Français</a></li>
				<li class="interwiki-gl"><a href="http://gl.wikipedia.org/wiki/P%C3%A1rkinson">Galego</a></li>
				<li class="interwiki-ko"><a href="http://ko.wikipedia.org/wiki/%ED%8C%8C%ED%82%A8%EC%8A%A8%EB%B3%91">한국어</a></li>
				<li class="interwiki-hr"><a href="http://hr.wikipedia.org/wiki/Parkinsonova_bolest">Hrvatski</a></li>
				<li class="interwiki-id"><a href="http://id.wikipedia.org/wiki/Penyakit_Parkinson">Bahasa Indonesia</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Morbo_di_Parkinson">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%9E%D7%97%D7%9C%D7%AA_%D7%A4%D7%A8%D7%A7%D7%99%D7%A0%D7%A1%D7%95%D7%9F">עברית</a></li>
				<li class="interwiki-ku"><a href="http://ku.wikipedia.org/wiki/Nexwe%C5%9Fiya_parkinson%C3%AA">Kurdî / كوردی</a></li>
				<li class="interwiki-lv"><a href="http://lv.wikipedia.org/wiki/P%C4%81rkinsona_slim%C4%ABba">Latviešu</a></li>
				<li class="interwiki-lb"><a href="http://lb.wikipedia.org/wiki/Parkinson-Krankheet">Lëtzebuergesch</a></li>
				<li class="interwiki-ml"><a href="http://ml.wikipedia.org/wiki/%E0%B4%AA%E0%B4%BE%E0%B4%B0%E0%B5%8D%E2%80%8D%E0%B4%95%E0%B5%8D%E0%B4%95%E0%B4%BF%E0%B4%A8%E0%B5%8D%E2%80%8D%E0%B4%B8%E0%B4%A3%E0%B5%8D%E2%80%8D%E0%B4%B8%E0%B5%8D_%E0%B4%B0%E0%B5%8B%E0%B4%97%E0%B4%82">മലയാളം</a></li>
				<li class="interwiki-ms"><a href="http://ms.wikipedia.org/wiki/Penyakit_Parkinson">Bahasa Melayu</a></li>
				<li class="interwiki-hu"><a href="http://hu.wikipedia.org/wiki/Parkinson-k%C3%B3r">Magyar</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Ziekte_van_Parkinson">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E3%83%91%E3%83%BC%E3%82%AD%E3%83%B3%E3%82%BD%E3%83%B3%E7%97%85">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Parkinsons_sykdom">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Choroba_Parkinsona">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Doen%C3%A7a_de_Parkinson">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%91%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C_%D0%9F%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%B0">Русский</a></li>
				<li class="interwiki-simple"><a href="http://simple.wikipedia.org/wiki/Parkinson%27s_disease">Simple English</a></li>
				<li class="interwiki-sr"><a href="http://sr.wikipedia.org/wiki/%D0%9F%D0%B0%D1%80%D0%BA%D0%B8%D0%BD%D1%81%D0%BE%D0%BD%D0%BE%D0%B2%D0%B0_%D0%B1%D0%BE%D0%BB%D0%B5%D1%81%D1%82">Српски / Srpski</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Parkinsonin_tauti">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Parkinsons_sjukdom">Svenska</a></li>
				<li class="interwiki-th"><a href="http://th.wikipedia.org/wiki/%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B8%9E%E0%B8%B2%E0%B8%A3%E0%B9%8C%E0%B8%81%E0%B8%B4%E0%B8%99%E0%B8%AA%E0%B8%B1%E0%B8%99">ไทย</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/Parkinson_hastal%C4%B1%C4%9F%C4%B1">Türkçe</a></li>
				<li class="interwiki-uk"><a href="http://uk.wikipedia.org/wiki/%D0%A5%D0%B2%D0%BE%D1%80%D0%BE%D0%B1%D0%B0_%D0%9F%D0%B0%D1%80%D0%BA%D1%96%D0%BD%D1%81%D0%BE%D0%BD%D0%B0">Українська</a></li>
				<li class="interwiki-yo"><a href="http://yo.wikipedia.org/wiki/%C3%80r%C3%B9n_Parkinson">Yorùbá</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E5%B8%95%E9%87%91%E6%A3%AE%E6%B0%8F%E7%97%87">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 11 April 2009, at 14:50 (UTC).</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv101 in 0.211 secs. --></body></html>
